US20110209246A1 - Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement - Google Patents
Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement Download PDFInfo
- Publication number
- US20110209246A1 US20110209246A1 US11/785,162 US78516207A US2011209246A1 US 20110209246 A1 US20110209246 A1 US 20110209246A1 US 78516207 A US78516207 A US 78516207A US 2011209246 A1 US2011209246 A1 US 2011209246A1
- Authority
- US
- United States
- Prior art keywords
- seq
- polynucleotide
- polypeptide
- plant
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
- A01G22/00—Cultivation of specific crops or plants not otherwise provided for
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8255—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving lignin biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8262—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield involving plant development
- C12N15/8269—Photosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8273—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for drought, cold, salt resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
Definitions
- sequence Listing Copy 1 and Sequence Listing Copy 2 Two copies of the sequence listing (Sequence Listing Copy 1 and Sequence Listing Copy 2) and a computer-readable form of the sequence listing, all on CD-Rs, each containing the file named pa — 00608.rpt, which is 235,202,560 bytes (measured in MS-DOS) and was created on Nov. 3, 2003, are hereby incorporated by reference.
- inventions in the field of plant biochemistry and genetics More specifically recombinant polynucleotides and recombinant polypeptides from Triticum aestivum for use in plant improvement are provided. Methods of using the recombinant polynucleotides and recombinant polypeptides for production of transgenic plants with improved biological characteristics are disclosed.
- transgenic plants with improved traits depends in part on the identification of polynucleotides that are useful for the production of transformed plants having desirable qualities.
- the discovery of polynucleotide sequences of genes, and the polypeptides encoded by such genes, is needed. Molecules comprising such polynucleotides may be used, for example, in recombinant DNA constructs useful for imparting unique genetic properties into transgenic plants.
- the present invention provides a recombinant polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582.
- the present invention also provides a recombinant polypeptide selected from the group consisting of SEQ ID NO: 105,583 through SEQ ID NO: 211,164.
- the present invention also provides a method of producing a plant having an improved property, wherein said method comprises transforming a plant with a recombinant construct comprising a promoter region functional in a plant cell operably joined to a polynucleotide comprising a coding sequence for a polypeptide associated with said property, and growing said transformed plant.
- the present invention provides recombinant polynucleotides and recombinant polypeptides from Triticum aestivum.
- the recombinant polynucleotides and recombinant polypeptides of the present invention find a number of uses, for example in recombinant DNA constructs, in physical arrays of molecules, for use as plant breeding markers, and for use in computer based storage and analysis systems.
- the recombinant polynucleotides of the present invention also find use in generation of transgenic plants to provide for increased or decreased expression of the polypeptides encoded by the recombinant polynucleotides provided herein.
- a “transgenic” organism is one whose genome has been altered by the incorporation of foreign genetic material or additional copies of native genetic material, e.g. by transformation or recombination. As a result of such biotechnological applications, plants, particularly crop plants, having improved properties are obtained.
- Crop plants of interest in the present invention include, but are not limited to soy, cotton, canola, maize, wheat, sunflower, sorghum, alfalfa, barley, millet, rice, tobacco, fruit and vegetable crops, and turf grass.
- the disclosed recombinant polynucleotides provide plants having improved yield resulting from improved utilization of key biochemical compounds, such as nitrogen, phosphorous and carbohydrate, or resulting from improved responses to environmental stresses, such as cold, heat, drought, salt, and attack by pests or pathogens.
- Recombinant polynucleotides of the present invention may be used to provide plants having improved growth and development, and ultimately increased yield, as the result of modified expression of plant growth regulators or modification of cell cycle or photosynthesis pathways.
- Other traits of interest that may be modified in plants using polynucleotides of the present invention include flavonoid content, seed oil and protein quantity and quality, herbicide tolerance, and rate of homologous recombination.
- the recombinant polynucleotides of the present invention may be present in the form of DNA, such as cDNA or genomic DNA, or as RNA, for example mRNA.
- the polynucleotides of the present invention may be single or double stranded and may represent the coding, or sense strand of a gene, or the non-coding, antisense, strand.
- the recombinant polynucleotides of this invention represent cDNA sequences from Triticum aestivum. DNA sequences representing the recombinant polynucleotides are provided herein as SEQ ID NO: 1 through SEQ ID NO: 105,582.
- recombinant polynucleotide refers to a polynucleotide produced by recombinant DNA technology.
- a recombinant polynucleotide may be produced by separation from substantially all other molecules normally associated with it in its native state.
- a recombinant polynucleotide may be greater than 60% free, greater than 75% free, greater than 90% free, or greater than 95% free from the other molecules (exclusive of solvent) present in the natural mixture.
- a recombinant polynucleotide may be separated from nucleic acids which normally flank the polynucleotide in nature.
- polynucleotides fused to regulatory or coding sequences with which they are not normally associated are considered recombinant polynucleotides herein.
- Such molecules are considered recombinant polynucleotides even when present, for example in the chromosome of a host cell, or in a nucleic acid solution.
- the term recombinant polynucleotide as used herein is not intended to encompass molecules present in their native state.
- a label can be any reagent that facilitates detection, including fluorescent labels, chemical labels, or modified bases, including nucleotides with radioactive elements, e.g. 32 P, 33 P, 35 S or 125 I such as 32 P deoxycytidine-5′-triphosphate ( 32 PdCTP).
- Recombinant polynucleotides of the present invention are capable of specifically hybridizing to other polynucleotides under certain circumstances.
- two polynucleotides are said to be capable of specifically hybridizing to one another if the two molecules are capable of forming an anti-parallel, double-stranded nucleic acid structure.
- a polynucleotide is said to be the “complement” of another polynucleotide if the molecules exhibit complete complementarity.
- molecules are said to exhibit “complete complementarity” when every nucleotide in each of the polynucleotides is complementary to the corresponding nucleotide of the other.
- Two polynucleotides are said to be “minimally complementary” if they can hybridize to one another with sufficient stability to permit them to remain annealed to one another under at least conventional “low-stringency” conditions.
- the polynucleotides are said to be “complementary” if they can hybridize to one another with sufficient stability to permit them to remain annealed to one another under conventional “high-stringency” conditions.
- Conventional stringency conditions are known to those skilled in the art and can be found, for example in Molecular Cloning: A Laboratory Manual, 3 rd edition Volumes 1, 2, and 3. J. F. Sambrook, D. W. Russell, and N. Irwin, Cold Spring Harbor Laboratory Press, 2000.
- Salt concentration and temperature in the wash step can be adjusted to alter hybridization stringency.
- conditions may vary from low stringency of about 2.0 ⁇ SSC at 40° C. to moderately stringent conditions of about 2.0 ⁇ SSC at 50° C. to high stringency conditions of about 0.2 ⁇ SSC at 50° C.
- sequence identity refers to the extent to which two optimally aligned polynucleotides or polypeptide sequences are invariant throughout a window of alignment of components, e.g. nucleotides or amino acids.
- An “identity fraction” for aligned segments of a test sequence and a reference sequence is the number of identical components which are shared by the two aligned sequences divided by the total number of components in the reference sequence segment, i.e. the entire reference sequence or a smaller defined part of the reference sequence.
- Percent identity is the identity fraction times 100. Comparison of sequences to determine percent identity can be accomplished by a number of well-known methods, including for example by using mathematical algorithms, such as those in the BLAST suite of sequence analysis programs.
- this invention provides recombinant polynucleotides comprising regions that encode polypeptides.
- the encoded polypeptides may be the complete protein encoded by the gene represented by the polynucleotide, or may be fragments of the encoded protein.
- polynucleotides provided herein encode polypeptides constituting a substantial portion of the complete protein. In another embodiment polynucleotides provided herein encode polypeptides constituting a sufficient portion of the complete protein to provide the relevant biological activity.
- recombinant polynucleotides of the present invention encode polypeptides involved in one or more important biological function in plants. Such recombinant polynucleotides may be expressed in transgenic plants to produce plants having improved phenotypic properties and/or improved response to stressful environmental conditions. See, for example, Table 1 in U.S. Pub. No. 2007/0044171 (the contents of this published patent application and the table therein are incorporated in their entireties, by reference) for a list of SEQ ID numbers representing the recombinant polynucleotides that may be expressed in transgenic plants to impart an improved plant property where improved plant properties are provided for each sequence in the PRODUCT_CAT_DESC column.
- Recombinant polynucleotides of the present invention are generally used to impart such improved properties by providing for enhanced protein activity in a transgenic organism, such as a transgenic plant, although in some cases, improved properties are obtained by providing for reduced protein activity in a transgenic plant.
- Reduced protein activity and enhanced protein activity are measured by reference to a wild type cell or organism and can be determined by direct or indirect measurement.
- Direct measurement of protein activity might include an analytical assay for the protein, per se, or enzymatic product of protein activity.
- Indirect assay might include measurement of a property affected by the protein.
- Enhanced protein activity can be achieved in a number of ways, for example by overproduction of mRNA encoding the protein or by gene shuffling.
- RNA messenger RNA
- methods to achieve overproduction of mRNA for example by providing increased recombinant copies of a gene or by introducing a recombinant construct having a heterologous promoter operably linked to a recombinant polynucleotide encoding a polypeptide into a target cell or organism.
- Reduced protein activity can be achieved by a variety of mechanisms including antisense, mutation, or knockout.
- Antisense RNA will reduce the level of expressed protein resulting in reduced protein activity as compared to wild type activity levels.
- a mutation in the gene encoding a protein may reduce the level of expressed protein and/or interfere with the function of expressed protein to cause reduced protein activity.
- the invention is a fragment of a disclosed recombinant polynucleotide consisting of oligonucleotides of at least 15, at least 16 or 17, at least 18 or 19, or at least 20 or more consecutive nucleotides.
- oligonucleotides are fragments of the larger recombinant polynucleotides having a sequence selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, and find use, for example as probes and primers for detection of the polynucleotides of the present invention.
- the present invention is a functional variant of a recombinant polynucleotide provided herein.
- a “functional variant” refers to any second polynucleotide varying from a first polynucleotide sequence in such a way so as not to significantly affect the function when compared to the function of the first polynucleotide.
- Such functional variants may be naturally occurring, including homologous polynucleotides from the same or a different species, or may be non-natural functional variants, for example polynucleotides synthesized using chemical synthesis methods, or generated using recombinant DNA techniques.
- degeneracy of the genetic code provides the possibility to substitute at least one base of the protein encoding sequence of a gene with a different base without causing the amino acid sequence of the polypeptide produced from the gene to be changed.
- a recombinant polynucleotide of the present invention may have any base sequence that has been changed from SEQ ID NO: 1 through SEQ ID NO: 105,582 by substitution in accordance with degeneracy of the genetic code. See for example, U.S. Pat. No. 5,500,365, which is hereby incorporated by reference.
- Polynucleotides of the present invention that are functional variants of the polynucleotides provided herein will generally demonstrate significant identity with the polynucleotides provided herein.
- polynucleotide homologs having at least about 60% sequence identity, at least about 70% sequence identity, at least about 80% sequence identity, at least about 85% sequence identity, and at least about 90%, 95% or even greater, such as 98% or 99% sequence identity with polynucleotide sequences described herein.
- this invention also provides recombinant polypeptides.
- Amino acid sequences of the recombinant polypeptides of the present invention are provided herein as SEQ ID NO: 105,583 through SEQ ID NO: 211,164.
- polypeptide refers to an unbranched chain of amino acid residues that are covalently linked by an amide linkage between the carboxyl group of one amino acid and the amino group of another.
- the term polypeptide can encompass whole proteins (i.e. a functional protein encoded by a particular gene), as well as fragments of proteins.
- the invention is a recombinant polypeptide which represents a whole protein.
- the invention is a recombinant polypeptide which represents a sufficient portion of an entire protein to impart the relevant biological activity of the protein.
- protein also includes molecules consisting of one or more polypeptide chains.
- a recombinant polypeptide of the present invention may also constitute an entire gene product, but only a portion of a functional oligomeric protein having multiple polypeptide chains.
- recombinant polypeptide refers to a polypeptide produced as a result of recombinant DNA technology.
- the term recombinant polypeptide as used herein is not intended to encompass molecules present in their native state.
- the invention is a recombinant polypeptide involved in one or more important biological properties in a plant.
- recombinant polypeptide may be produced in transgenic plants to provide plants having improved phenotypic properties and/or improved response to stressful environmental conditions.
- decreased expression of such polypeptide may be desired, such decreased expression being obtained by use of the polynucleotide sequences provided herein, for example in antisense or cosuppression methods. See, Table 1 from U.S. Pub. No. 2007/0044171 for a list of improved plant properties and PROTEIN_NUM for the recombinant polypeptide whose expression may be altered in transgenic plants to impart such improvements.
- a summary of such improved properties and polypeptides of interest for increased or decreased expression is provided below.
- Yield/Nitrogen Yield improvement by improved nitrogen flow, sensing, uptake, storage and/or transport.
- Polypeptides useful for imparting such properties include those involved in aspartate and glutamate biosynthesis, polypeptides involved in aspartate and glutamate transport, polypeptides associated with the TOR (Target of Rapamycin) pathway, nitrate transporters, ammonium transporters, chlorate transporters and polypeptides involved in tetrapyrrole biosynthesis.
- Yield/Carbohydrate Yield improvement by effects on carbohydrate metabolism, for example by increased sucrose production and/or transport.
- Polypeptides useful for improved yield by effects on carbohydrate metabolism include polypeptides involved in sucrose or starch metabolism, carbon assimilation or carbohydrate transport, including, for example sucrose transporters or glucose/hexose transporters, enzymes involved in glycolysis/gluconeogenesis, the pentose phosphate cycle, or raffinose biosynthesis, and polypeptides involved in glucose signaling, such as SNF1 complex proteins.
- Yield/Photosynthesis Yield improvement resulting from increased photosynthesis.
- Polypeptides useful for increasing the rate of photosynthesis include phytochrome, photosystem I and II proteins, electron carriers, ATP synthase, NADH dehydrogenase and cytochrome oxidase.
- Yield/Phosphorus Yield improvement resulting from increased phosphorus uptake, transport or utilization.
- Polypeptides useful for improving yield in this manner include phosphatases and phosphate transporters.
- Yield/Stress tolerance Yield improvement resulting from improved plant growth and development by helping plants to tolerate stressful growth conditions.
- Polypeptides useful for improved stress tolerance under a variety of stress conditions include polypeptides involved in gene regulation, such as serine/threonine-protein kinases, MAP kinases, MAP kinase kinases, and MAP kinase kinases; polypeptides that act as receptors for signal transduction and regulation, such as receptor protein kinases; intracellular signaling proteins, such as protein phosphatases, GTP binding proteins, and phospholipid signaling proteins; polypeptides involved in arginine biosynthesis; polypeptides involved in ATP metabolism, including for example ATPase, adenylate transporters, and polypeptides involved in ATP synthesis and transport; polypeptides involved in glycine betaine, jasmonic acid, flavonoid or steroid biosynthesis; and hemoglobin. Enhanced or reduced activity of such polypeptides
- Polypeptides of interest for improving plant tolerance to cold or freezing temperatures include polypeptides involved in biosynthesis of trehalose or raffinose, polypeptides encoded by cold induced genes, fatty acyl desaturases and other polypeptides involved in glycerolipid or membrane lipid biosynthesis, which find use in modification of membrane fatty acid composition, alternative oxidase, calcium-dependent protein kinases, LEA proteins and uncoupling protein.
- Polypeptides of interest for improving plant tolerance to heat include polypeptides involved in biosynthesis of trehalose, polypeptides involved in glycerolipid biosynthesis or membrane lipid metabolism (for altering membrane fatty acid composition), heat shock proteins and mitochondrial NDK.
- Osmotic tolerance Polypeptides of interest for improving plant tolerance to extreme osmotic, conditions include polypeptides involved in proline biosynthesis.
- Drought tolerance Polypeptides of interest for improving plant tolerance to drought conditions include aquaporins, polypeptides involved in biosynthesis of trehalose or wax, LEA proteins and invertase.
- Polypeptides of interest for improving plant tolerance to effects of plant pests or pathogens include proteases, polypeptides involved in anthocyanin biosynthesis, polypeptides involved in cell wall metabolism, including cellulases, glucosidases, pectin methylesterase, pectinase, polygalacturonase, chitinase, chitosanase, and cellulose synthase, and polypeptides involved in biosynthesis of terpenoids or indole for production of bioactive metabolites to provide defense against herbivorous insects.
- Cell cycle modification Polypeptides encoding cell cycle enzymes and regulators of the cell cycle pathway are useful for manipulating growth rate in plants to provide early vigor and accelerated maturation leading to improved yield. Improvements in quality traits, such as seed oil content, may also be obtained by expression of cell cycle enzymes and cell cycle regulators.
- Polypeptides of interest for modification of cell cycle pathway include cyclins and EIF5alpha pathway proteins, polypeptides involved in polyamine metabolism, polypeptides which act as regulators of the cell cycle pathway, including cyclin-dependent kinases (CDKs), CDK-activating kinases, CDK-inhibitors, Rb and Rb-binding proteins, and transcription factors that activate genes involved in cell proliferation and division, such as the E2F family of transcription factors, proteins involved in degradation of cyclins, such as cullins, and plant homologs of tumor suppressor polypeptides.
- CDKs cyclin-dependent kinases
- CDK-activating kinases CDK-inhibitors
- Rb and Rb-binding proteins transcription factors that activate genes involved in cell proliferation and division, such as the E2F family of transcription factors, proteins involved in degradation of cyclins, such as cullins, and plant homologs of tumor suppressor polypeptides.
- Seed protein yield/content Polypeptides useful for providing increased seed protein quantity and/or quality include polypeptides involved in the metabolism of amino acids in plants, particularly polypeptides involved in biosynthesis of methionine/cysteine and lysine, amino acid transporters, amino acid efflux carriers, seed storage proteins, proteases, and polypeptides involved in phytic acid metabolism.
- Seed oil yield/content Polypeptides useful for providing increased seed oil quantity and/or quality include polypeptides involved in fatty acid and glycerolipid biosynthesis, beta-oxidation enzymes, enzymes involved in biosynthesis of nutritional compounds, such as carotenoids and tocopherols, and polypeptides that increase embryo size or number or thickness of aleurone.
- Polypeptides useful for imparting improved disease responses to plants include polypeptides encoded by cercosporin induced genes, antifungal proteins and proteins encoded by R-genes or SAR genes. Expression of such polypeptides in transgenic plants will provide an increase in disease resistance ability of plants.
- Galactomannananan biosynthesis Polypeptides involved in production of galactomannans are of interest for providing plants having increased and/or modified reserve polysaccharides for use in food, pharmaceutical, cosmetic, paper and paint industries.
- Flavonoid/isoflavonoid metabolism in plants Polypeptides of interest for modification of flavonoid/isoflavonoid metabolism in plants include cinnamate-4-hydroxylase, chalcone synthase and flavonol synthase. Enhanced or reduced activity of such polypeptides in transgenic plants will provide changes in the quantity and/or speed of flavonoid metabolism in plants and may improve disease resistance by enhancing synthesis of protective secondary metabolites or improving signaling pathways governing disease resistance.
- Plant growth regulators Polypeptides involved in production of substances that regulate the growth of various plant tissues are of interest in the present invention and may be used to provide transgenic plants having altered morphologies and improved plant growth and development profiles leading to improvements in yield and stress response.
- polypeptides involved in the biosynthesis of plant growth hormones such as gibberellins, cytokinins, auxins, ethylene and abscisic acid, and other proteins involved in the activity and/or transport of such polypeptides, including for example, cytokinin oxidase, cytokinin/purine permeases, F-box proteins, G-proteins and phytosulfokines.
- Polypeptides of interest for producing plants having tolerance to plant herbicides include polypeptides involved in the shikimate pathway, which are of interest for providing glyphosate tolerant plants. Such polypeptides include polypeptides involved in biosynthesis of chorismate, phenylalanine, tyrosine and tryptophan.
- Transcription factors in plants Transcription factors play a key role in plant growth and development by controlling the expression of one or more genes in temporal, spatial and physiological specific patterns. Enhanced or reduced activity of such polypeptides in transgenic plants will provide significant changes in gene transcription patterns and provide a variety of beneficial effects in plant growth, development and response to environmental conditions.
- Transcription factors of interest include, but are not limited to myb transcription factors, including helix-turn-helix proteins, homeodomain transcription factors, leucine zipper transcription factors, MADS transcription factors, transcription factors having AP2 domains, zinc finger transcription factors, CCAAT binding transcription factors, ethylene responsive transcription factors, transcription initiation factors and UV damaged DNA binding proteins.
- Homologous recombination Increasing the rate of homologous recombination in plants is useful for accelerating the introgression of transgenes into breeding varieties by backcrossing, and to enhance the conventional breeding process by allowing rare recombinants between closely linked genes in phase repulsion to be identified more easily.
- Polypeptides useful for expression in plants to provide increased homologous recombination include polypeptides involved in mitosis and/or meiosis, including for example, resolvases and polypeptide members of the RAD52 epistasis group.
- Lignin biosynthesis Polypeptides involved in lignin biosynthesis are of interest for increasing plants' resistance to lodging and for increasing the usefulness of plant materials as biofuels.
- the function of a recombinant polypeptide is determined by comparison of the amino acid sequence of the recombinant polypeptide to amino acid sequences of known polypeptides.
- a variety of homology based search algorithms are available to compare a query sequence to a protein database, including for example, BLAST, FASTA, and Smith-Waterman.
- BLASTX and BLASTP algorithms are used to provide protein function information. A number of values are examined in order to assess the confidence of the function assignment. Useful measurements include “E-value” (also shown as “hit_p”), “percent identity”, “percent query coverage”, and “percent hit coverage”.
- E-value In BLAST, E-value, or expectation value, represents the number of different alignments with scores equivalent to or better than the raw alignment score, S, that are expected to occur in a database search by chance. The lower the E value, the more significant the match. Because database size is an element in E-value calculations, E-values obtained by BLASTing against public databases, such as GENBANK, have generally increased over time for any given query/entry match. In setting criteria for confidence of polypeptide function prediction, a “high” BLAST match is considered herein as having an E-value for the top BLAST hit provided in Table 1 from U.S. Pub. No.
- the top BLAST hit and corresponding E values are provided in Table 1 from U.S. Pub. No. 2007/0044171.
- Percent identity refers to the percentage of identically matched amino acid residues that exist along the length of that portion of the sequences which is aligned by the BLAST algorithm. In setting criteria for confidence of polypeptide function prediction, a “high” BLAST match is considered herein as having percent identity for the top BLAST hit provided in Table 1 from U.S. Pub. No. 2007/0044171 of at least 70%; a medium percent identity value is 35% to 70%; and a low percent identity is less than 35%.
- the protein function assignment in the present invention is determined using combinations of E-values, percent identity, query coverage and hit coverage.
- Query coverage refers to the percent of the query sequence that is represented in the BLAST alignment.
- Hit coverage refers to the percent of the database entry that is represented in the BLAST alignment.
- function of a query polypeptide is inferred from function of a protein homolog where either (1) hit_p ⁇ 1e-30 or % identity>35% AND query_coverage>50% AND hit_coverage>50%, or (2) hit_p ⁇ 1e-8 AND query_coverage>70% AND hit_coverage>70%.
- Another aspect of the invention comprises a functional variant which differs in one or more amino acids from those of a recombinant polypeptide provided herein as the result of one or more conservative amino acid substitutions.
- one or more amino acids in a reference sequence can be substituted with at least one other amino acid, the charge and polarity of which are similar to that of the native amino acid, resulting in a silent change.
- valine is a conservative substitute for alanine
- threonine is a conservative substitute for serine.
- Conservative substitutions for an amino acid within a polypeptide sequence can be selected from other members of the class to which the naturally occurring amino acid belongs.
- Amino acids can be divided into the following four groups: (1) acidic amino acids, (2) basic amino acids, (3) neutral polar amino acids, and (4) neutral nonpolar amino acids.
- Representative amino acids within these various groups include, but are not limited to: (1) acidic (negatively charged) amino acids such as aspartic acid and glutamic acid; (2) basic (positively charged) amino acids such as arginine, histidine, and lysine; (3) neutral polar amino acids such as glycine, serine, threonine, cysteine, tyrosine, asparagine, and glutamine; and (4) neutral nonpolar (hydrophobic) amino acids such as alanine, leucine, isoleucine, valine, proline, phenylalanine, tryptophan, and methionine.
- conserveed substitutes for an amino acid within a polypeptide sequence can be selected from other members of the group to which the naturally occurring amino acid belongs.
- a group of amino acids having aliphatic side chains is glycine, alanine, valine, leucine, and isoleucine
- a group of amino acids having aliphatic-hydroxyl side chains is serine and threonine
- a group of amino acids having amide-containing side chains is asparagine and glutamine
- a group of amino acids having aromatic side chains is phenylalanine, tyrosine, and tryptophan
- a group of amino acids having basic side chains is lysine, arginine, and histidine
- a group of amino acids having sulfur-containing side chains is cysteine and methionine.
- a recombinant polypeptide of the invention may differ in one or more amino acids as the result of deletion or insertion of one or more amino acids in a native sequence. See for example, U.S. Pat. No. 5,500,365, which is hereby incorporated by reference.
- One embodiment of the present invention is a variant which has the same function as a recombinant polypeptide provided herein, but with increased or decreased activity or altered specificity.
- Such variations in protein activity can be achieved by mutagenesis or may exist naturally in polypeptides encoded by related genes, for example in a related polypeptide encoded by a different allele or in a different species.
- Variant polypeptides may be obtained by well known nucleic acid or protein screening methods using DNA or antibody probes, for example by screening libraries for genes encoding related polypeptides, or in the case of expression libraries, by screening directly for variant polypeptides. Screening methods for obtaining a modified protein or enzymatic activity of interest by mutagenesis are disclosed in U.S. Pat. No.
- Polypeptides of the present invention that are functional variants of the polypeptides provided herein will generally demonstrate significant identity with the polypeptides provided herein.
- One embodiment of the invention is a polypeptide having at least about 35% sequence identity, at least about 50% sequence identity, at least about 60% sequence identity, at least about 70% sequence identity, at least about 80% sequence identity, and at least about 85%, 90%, 95% or even greater sequence identity with a recombinant polypeptide sequence described herein.
- One embodiment of the invention is a polypeptide having an amino acid sequence provided herein (reference polypeptides) and functional variants of such reference polypeptide, wherein such functional variant comprises at least about 50 consecutive amino acids having at least about 90% identity to about a 50 amino acid polypeptide fragment of said reference polypeptide.
- the invention encompasses the use of recombinant polynucleotides in recombinant constructs, i.e. constructs comprising recombinant polynucleotides that are constructed or modified outside of cells and that join nucleic acids that are not found joined in nature.
- recombinant polynucleotides of the invention can be inserted into recombinant DNA constructs that can then be introduced into a host cell of choice for expression of the encoded polypeptide or to provide for reduction of expression of the encoded polypeptide, for example by antisense or cosuppression methods.
- Potential host cells include both prokaryotic and eukaryotic cells.
- One embodiment of the invention uses a recombinant polynucleotide of the present invention for preparation of recombinant constructs for use in plant transformation.
- exogenous refers to a nucleic acid molecule, for example a recombinant DNA construct comprising a recombinant polynucleotide of the present invention, produced outside the organism, e.g. plant, into which it is introduced.
- An exogenous nucleic acid molecule can have a naturally occurring or non-naturally occurring nucleic acid sequence.
- an exogenous nucleic acid molecule can be derived from the same species into which it is introduced or from a different species.
- exogenous genetic material may be transferred into either monocot or dicot plants including, but not limited to, soy, cotton, canola, maize, teosinte, wheat, rice, and Arabidopsis plants.
- Transformed plant cells comprising such exogenous genetic material may be regenerated to produce whole transformed plants.
- Exogenous genetic material may be transferred into a plant cell by the use of a recombinant construct, also known as a vector, designed for such a purpose.
- a recombinant construct can comprise a number of sequence elements, including promoters, encoding regions, and selectable markers.
- Recombinant constructs are available which have been designed to replicate in both E. coli and A. tumefaciens and have all of the features required for transferring large inserts of DNA into plant chromosomes. Design of such vectors is generally within the skill of the art.
- a recombinant construct will generally include a plant promoter to direct transcription of the protein-encoding region or the antisense sequence of choice.
- a plant promoter to direct transcription of the protein-encoding region or the antisense sequence of choice.
- Numerous promoters, which are active in plant cells, have been described in the literature. These include the nopaline synthase (NOS) promoter and octopine synthase (OCS) promoters carried on tumor-inducing plasmids of Agrobacterium tumefaciens or caulimovirus promoters such as the Cauliflower Mosaic Virus (CaMV) 19S or 35S promoter (U.S. Pat. No. 5,352,605), and the Figwort Mosaic Virus (FMV) 35S-promoter (U.S. Pat. No.
- CaMV Cauliflower Mosaic Virus
- FMV Figwort Mosaic Virus
- promoter enhancers such as the CaMV 35S enhancer or a tissue specific enhancer, may be used to enhance gene transcription levels. Enhancers often are found 5′ to the start of transcription in a promoter that functions in eukaryotic cells, but can often be inserted in the forward or reverse orientation 5′ or 3′ to the coding sequence. In some instances, these 5′ enhancing elements are introns. Deemed to be particularly useful as enhancers are the 5′ introns of the rice actin 1 and rice actin 2 genes.
- enhancers examples include elements from octopine synthase genes, the maize alcohol dehydrogenase gene intron 1, elements from the maize shrunken 1 gene, the sucrose synthase intron, the TMV omega element, and promoters from non-plant eukaryotes.
- Recombinant constructs can also contain one or more 5′ non-translated leader sequences which serve to enhance polypeptide production from the resulting mRNA transcripts.
- sequences may be derived from the promoter selected to express the gene or can be specifically modified to increase translation of the mRNA.
- regions may also be obtained from viral RNAs, from suitable eukaryotic genes, or from a synthetic gene sequence.
- Recombinant constructs may also include, with the coding region of interest, a nucleic acid sequence that acts, in whole or in part, to terminate transcription of that region.
- a nucleic acid sequence that acts, in whole or in part, to terminate transcription of that region.
- 3′ untranslated sequence which may be used is a 3′ UTR from the nopaline synthase gene (nos 3′) of Agrobacterium tumefaciens.
- Other 3′ termination regions of interest include those from a gene encoding the small subunit of a ribulose-1,5-bisphosphate carboxylase-oxygenase (rbcS), and more specifically, from a rice rbcS gene (U.S. Pat. No.
- Recombinant constructs may also include a selectable marker.
- Selectable markers may be used to select for plants or plant cells that contain the exogenous genetic material.
- Useful selectable marker genes include those conferring resistance to antibiotics such as kanamycin (nptII), hygromycin B (aph IV) and gentamycin (aac3 and aacC4) or resistance to herbicides such as glufosinate (bar or pat) and glyphosate (EPSPS). Examples of such selectable markers are illustrated in U.S. Pat. Nos. 5,550,318; 5,633,435; 5,780,708 and 6,118,047, all of which are hereby incorporated by reference.
- Recombinant constructs may also include a screenable marker.
- Screenable markers may be used to monitor transformation.
- Exemplary screenable markers include genes expressing a colored or fluorescent protein such as a luciferase or green fluorescent protein (GFP), a ⁇ -glucuronidase or uidA gene (GUS) which encodes an enzyme for which various chromogenic substrates are known or an R-locus gene, which encodes a product that regulates the production of anthocyanin pigments (red color) in plant tissues.
- GFP green fluorescent protein
- GUS ⁇ -glucuronidase
- uidA gene GUS
- Other possible selectable and/or screenable marker genes will be apparent to those of skill in the art.
- Recombinant constructs may also include a transit peptide for targeting of a gene target to a plant organelle, particularly to a chloroplast, leucoplast or other plastid organelle, see for example U.S. Pat. No. 5,188,642, which is hereby incorporated by reference.
- recombinant constructs of the present invention may also include T-DNA border regions flanking the DNA to be inserted into the plant genome to provide for transfer of the DNA into the plant host chromosome as discussed in more detail below.
- An exemplary plasmid that finds use in such transformation methods is pMON18365, a T-DNA vector that can be used to clone exogenous genes and transfer them into plants using Agrobacterium -mediated transformation. See published U.S. Patent Application 20030024014, which is hereby incorporated by reference. This vector contains the left border and right border sequences necessary for Agrobacterium transformation.
- the plasmid also has origins of replication for maintaining the plasmid in both E. coli and Agrobacterium tumefaciens strains.
- a candidate gene is prepared for insertion into the T-DNA vector, for example using well-known gene cloning techniques such as PCR. Restriction sites may be introduced onto each end of the gene to facilitate cloning.
- candidate genes may be amplified by PCR techniques using a set of primers. Both the amplified DNA and the cloning vector are cut with the same restriction enzymes, for example, NotI and PstI. The resulting fragments are gel-purified, ligated together, and transformed into E. coli. Plasmid DNA containing the vector with inserted gene may be isolated from E. coli cells selected for spectinomycin resistance, and the presence of the desired insert verified by digestion with the appropriate restriction enzymes.
- Undigested plasmid may then be transformed into Agrobacterium tumefaciens using techniques well known to those in the art, and transformed Agrobacterium cells containing the vector of interest selected based on spectinomycin resistance.
- transformed Agrobacterium cells containing the vector of interest selected based on spectinomycin resistance.
- Methods and materials for transforming plants by introducing a transgenic DNA construct into a plant genome in the practice of this invention can include any of the well-known and demonstrated methods including electroporation as illustrated in U.S. Pat. No. 5,384,253, microprojectile bombardment as illustrated in U.S. Pat. Nos. 5,015,580; 5,550,318; 5,538,880; 6,160,208; 6,399,861 and 6,403,865, Agrobacterium -mediated transformation as illustrated in U.S. Pat. Nos. 5,635,055; 5,824,877; 5,591,616; 5,981,840 and 6,384,301, and protoplast transformation as illustrated in U.S. Pat. No. 5,508,184, all of which are hereby incorporated by reference.
- any of the recombinant polynucleotides of the present invention may be introduced into a plant cell in a permanent or transient manner in combination with other genetic elements such as vectors, promoters enhancers etc. Further any of the recombinant polynucleotides of the present invention may be introduced into a plant cell in a manner that allows for production of the polypeptide or fragment thereof encoded by the recombinant polynucleotide in the plant cell, or in a manner that provides for decreased expression of an endogenous gene and concomitant decreased production of protein.
- transgenic plants can also be mated to produce offspring that contain two independently segregating added, exogenous genes. Selfing of appropriate progeny can produce plants that are homozygous for both added, exogenous genes that encode a polypeptide of interest. Back-crossing to a parental plant and out-crossing with a non-transgenic plant are also contemplated, as is vegetative propagation.
- Expression of the recombinant polynucleotides of the present invention and the concomitant production of polypeptides encoded by the recombinant polynucleotides is of interest for production of transgenic plants having improved properties, particularly, improved properties which result in crop plant yield improvement.
- Expression of recombinant polypeptides of the present invention in plant cells may be evaluated by specifically identifying the protein products of the introduced genes or evaluating the phenotypic changes brought about by their expression. It is noted that when the polypeptide being produced in a transgenic plant is native to the target plant species, quantitative analyses comparing the transformed plant to wild type plants may be required to demonstrate increased expression of the polypeptide of this invention.
- Assays for the production and identification of specific proteins make use of various physical-chemical, structural, functional, or other properties of the proteins.
- Unique physical-chemical or structural properties allow the proteins to be separated and identified by electrophoretic procedures, such as native or denaturing gel electrophoresis or isoelectric focusing, or by chromatographic techniques such as ion exchange or gel exclusion chromatography.
- the unique structures of individual proteins offer opportunities for use of specific antibodies to detect their presence in formats such as an ELISA assay. Combinations of approaches may be employed with even greater specificity such as western blotting in which antibodies are used to locate individual gene products that have been separated by electrophoretic techniques. Additional techniques may be employed to absolutely confirm the identity of the product of interest such as evaluation by amino acid sequencing following purification. Although these are among the most commonly employed, other procedures may be additionally used.
- Assay procedures may also be used to identify the expression of proteins by their functionality, particularly where the expressed protein is an enzyme capable of catalyzing chemical reactions involving specific substrates and products. These reactions may be measured, for example in plant extracts, by providing and quantifying the loss of substrates or the generation of products of the reactions by physical and/or chemical procedures.
- the expression of a gene product is determined by evaluating the phenotypic results of its expression. Such evaluations may be simply as visual observations, or may involve assays. Such assays may take many forms including but not limited to analyzing changes in the chemical composition, morphology, or physiological properties of the plant. Chemical composition may be altered by expression of genes encoding enzymes or storage proteins which change amino acid composition and may be detected by amino acid analysis, or by enzymes which change starch quantity which may be analyzed by near infrared reflectance spectrometry. Morphological changes may include greater stature or thicker stalks.
- Plants with decreased expression of a gene of interest can also be achieved through the use of polynucleotides of the present invention, for example by expression of antisense nucleic acids, or by identification of plants transformed with sense expression constructs that exhibit cosuppression effects.
- Antisense approaches are a way of preventing or reducing gene function by targeting the genetic material as disclosed in U.S. Pat. Nos. 4,801,540; 5,107,065; 5,759,829; 5,910,444; 6,184,439; and 6,198,026, all of which are hereby incorporated by reference.
- the objective of the antisense approach is to use a sequence complementary to the target gene to block its expression and create a mutant cell line or organism in which the level of a single chosen protein is selectively reduced or abolished:
- Antisense techniques have several advantages over other ‘reverse genetic’ approaches.
- the site of inactivation and its developmental effect can be manipulated by the choice of promoter for antisense genes or by the timing of external application or microinjection.
- Antisense can manipulate its specificity by selecting either unique regions of the target gene or regions where it shares homology to other related genes.
- RNA that is complementary to the target mRNA is introduced into cells, resulting in specific RNA:RNA duplexes being formed by base pairing between the antisense substrate and the target.
- the process involves the introduction and expression of an antisense gene sequence.
- an antisense gene sequence is one in which part or all of the normal gene sequences are placed under a promoter in inverted orientation so that the ‘wrong’ or complementary strand is transcribed into a noncoding antisense RNA that hybridizes with the target mRNA and interferes with its expression.
- An antisense vector is constructed by standard procedures and introduced into cells by transformation, transfection, electroporation, microinjection, infection, etc. The type of transformation and choice of vector will determine whether expression is transient or stable.
- the promoter used for the antisense gene may influence the level, timing, tissue, specificity, or inducibility of the antisense inhibition.
- gene suppression means any of the well-known methods for suppressing expression of protein from a gene including sense suppression, anti-sense suppression and RNAi suppression. In suppressing genes to provide plants with a desirable phenotype, anti-sense and RNAi gene suppression methods are preferred.
- anti-sense regulation of gene expression in plant cells see U.S. Pat. No. 5,107,065.
- RNAi gene suppression in plants by transcription of a dsRNA see U.S. Pat. No. 6,506,559, U.S. Patent Application Publication No. 2002/0168707 A1, and U.S. patent applications Ser. No.
- RNAi Suppression of an gene by RNAi can be achieved using a recombinant DNA construct having a promoter operably linked to a DNA element comprising a sense and anti-sense element of a segment of genomic DNA of the gene, e.g., a segment of at least about 23 nucleotides, more preferably about 50 to 200 nucleotides where the sense and anti-sense DNA components can be directly linked or joined by an intron or artificial DNA segment that can form a loop when the transcribed RNA hybridizes to form a hairpin structure.
- genomic DNA from a polymorphic locus of SEQ ID NO: 1 through SEQ ID NO: 105,582 can be used in a recombinant construct for suppression of a cognate gene by RNAi suppression.
- Insertion mutations created by transposable elements may also prevent gene function. For example, in many dicot plants, transformation with the T-DNA of Agrobacterium may be readily achieved and large numbers of transformants can be rapidly obtained. Also, some species have lines with active transposable elements that can efficiently be used for the generation of large numbers of insertion mutations, while some other species lack such options.
- Mutant plants produced by Agrobacterium or transposon mutagenesis and having altered expression of a polypeptide of interest can be identified using the polynucleotides of the present invention. For example, a large population of mutated plants may be screened with polynucleotides encoding the polypeptide of interest to detect mutated plants having an insertion in the gene encoding the polypeptide of interest.
- polynucleotides of the present invention may be used in site-directed mutagenesis.
- Site-directed mutagenesis may be utilized to modify nucleic acid sequences, particularly as it is a technique that allows one or more of the amino acids encoded by a nucleic acid molecule to be altered (e.g., a threonine to be replaced by a methionine).
- Three basic methods for site-directed mutagenesis are often employed. These are cassette mutagenesis, primer extension, and methods based upon PCR.
- the recombinant polynucleotides or recombinant polypeptides of this invention may be used to prepare arrays of target molecules arranged on a surface of a substrate.
- the target molecules may be known molecules, e.g. polynucleotides (including oligonucleotides) or polypeptides, which are capable of binding to specific probes, such as complementary nucleic acids or specific antibodies.
- the target molecules may be immobilized, e.g. by covalent or non-covalent bonding, to the surface in small amounts of substantially purified and isolated molecules in a grid pattern. By immobilized it is meant that the target molecules maintain their position relative to the solid support under hybridization and washing conditions.
- Target molecules are deposited in small footprint, isolated quantities of “spotted elements” of preferably single-stranded polynucleotide preferably arranged in rectangular grids in a density of about 30 to 100 or more, e.g. up to about 1000, spotted elements per square centimeter.
- the arrays comprise at least about 100 or more, e.g. at least about 1000 to 5000, distinct target polynucleotides per unit substrate.
- the economics of arrays favors a high density design criteria provided that the target molecules are sufficiently separated so that the intensity of the indicia of a binding event associated with highly expressed probe molecules does not overwhelm and mask the indicia of neighboring binding events.
- each spotted element may contain up to about 10 7 or more copies of the target molecule, e.g. single stranded cDNA, on glass substrates or nylon substrates.
- Arrays of this invention may be prepared with molecules from a single species, preferably a plant species, or with molecules from other species, particularly other plant species. Arrays with target molecules from a single species can be used with probe molecules from the same species or a different species due to the ability of cross species homologous genes to hybridize. It is generally preferred for high stringency hybridization that the target and probe molecules are from the same species.
- the organism of interest is a plant and the target molecules are polynucleotides or oligonucleotides with nucleic acid sequences having at least about 80 percent sequence identity to a corresponding sequence of the same length in a recombinant polynucleotide having a sequence selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582 or complements thereof.
- At least about 10% of the target molecules on an array have at least about 15 consecutive nucleotides of sequence having at least about 80% and up to about 100% identity with a corresponding sequence of the same length in a recombinant polynucleotide having a sequence selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582 or complements or fragments thereof.
- arrays are useful in a variety of applications, including gene discovery, genomic research, molecular breeding and bioactive compound screening.
- One use of arrays is in the analysis of differential gene transcription, e.g. transcription profiling where the production of mRNA in different cells, normally a cell of interest and a control, is compared and discrepancies in gene expression are identified. In such assays, the presence of discrepancies indicates a difference in gene expression levels in the cells being compared.
- Such information is useful for the identification of the types of genes expressed in a particular cell or tissue type in a known environment.
- Such applications generally involve the following steps: (a) preparation of probe, e.g.
- a probe may be prepared with RNA extracted from a given cell line or tissue.
- the probe may be produced by reverse transcription of mRNA or total RNA and labeled with radioactive or fluorescent labeling.
- a probe is typically a mixture containing many different sequences in various amounts, corresponding to the numbers of copies of the original mRNA species extracted from the sample.
- the initial RNA sample for probe preparation will typically be derived from a physiological source.
- the physiological source may be selected from a variety of organisms, with physiological sources of interest including single celled organisms such as yeast and multicellular organisms, including plants and animals, particularly plants, where the physiological sources from multicellular organisms may be derived from particular organs or tissues of the multicellular organism, or from isolated cells derived from an organ, or tissue of the organism.
- the physiological sources may also be multicellular organisms at different developmental stages (e.g., 10-day-old seedlings), or organisms grown under different environmental conditions (e.g., drought-stressed plants) or treated with chemicals.
- the physiological source may be subjected to a number of different processing steps, where such processing steps might include tissue homogenation, cell isolation and cytoplasmic extraction, nucleic acid extraction and the like, where such processing steps are known to the those of skill in the art.
- processing steps might include tissue homogenation, cell isolation and cytoplasmic extraction, nucleic acid extraction and the like, where such processing steps are known to the those of skill in the art.
- Methods of isolating RNA from cells, tissues, organs or whole organisms are well known to those skilled in the art.
- the sequence of the molecules of this invention can be provided in a variety of media to facilitate use thereof. Such media may provide a subset thereof in a form that allows a skilled artisan to examine the sequences.
- about 20, about 50, about 100, and about 200 or more of the polynucleotide and/or the polypeptide sequences of the present invention can be recorded on computer readable media.
- “computer readable media” refers to any medium that can be read and accessed directly by a computer.
- Such media include, but are not limited to: magnetic storage media, such as floppy discs, hard disc, storage medium, and magnetic tape; optical storage media such as CD-ROM; electrical storage media such as RAM and ROM; and hybrids of these categories such as magnetic/optical storage media.
- magnetic storage media such as floppy discs, hard disc, storage medium, and magnetic tape
- optical storage media such as CD-ROM
- electrical storage media such as RAM and ROM
- hybrids of these categories such as magnetic/optical storage media.
- “recorded” refers to a process for storing information on computer readable media.
- a skilled artisan can readily adopt any of the presently known methods for recording information on computer readable media to generate media comprising the nucleotide sequence information of the present invention.
- a variety of data storage structures are available to a skilled artisan for creating a computer readable medium having recorded thereon a nucleotide sequence of the present invention. The choice of the data storage structure will generally be based on the means chosen to access the stored information.
- a variety of data processor programs and formats can be used to store the nucleotide sequence information of the present invention on computer readable media.
- sequence information can be represented in a word processing text file, formatted in commercially-available software such as WordPerfect and Microsoft Word, or represented in the form of an ASCII file, stored in a database application, such as DB2, Sybase, Oracle, or the like.
- a skilled artisan can readily adapt any number of data processor structuring formats (e.g., text file or database) in order to obtain a computer readable medium having recorded thereon the nucleotide sequence information of the present invention.
- ORFs are polypeptide encoding fragments within the sequences of the present invention and are useful in producing commercially important polypeptides such as enzymes used in amino acid biosynthesis, metabolism, transcription, translation, RNA processing, nucleic acid and a protein degradation, protein modification, and DNA replication, restriction, modification, recombination, and repair.
- One embodiment of the invention provides systems, particularly computer-based systems, which contain the sequence information described herein. Such systems are designed to identify commercially important fragments of the nucleic acid molecule of the present invention.
- a computer-based system refers to the hardware, software, and memory used to analyze the sequence information of the present invention. A skilled artisan can readily appreciate that any one of the currently available computer-based systems are suitable for use in the present invention.
- the computer-based systems of the present invention comprise a database having stored therein a polynucleotide sequence, polypeptide sequence, or both of the present invention and the necessary hardware and software for supporting and implementing a homology search.
- database refers to memory system that can store searchable nucleotide sequence information.
- query sequence is a polynucleotide sequence, or a polypeptide sequence, or a polynucleotide sequence corresponding to a polypeptide sequence, or a polypeptide sequence corresponding to a polynucleotide sequence, that is used to query a collection of polynucleotide or polypeptide sequences.
- homology search refers to one or more programs which are implemented on the computer-based system to compare a query sequence, i.e., gene or peptide or a conserved region (motif), with the sequence information stored within the database. Homology searches are used to identify segments and/or regions of the sequence of the present invention that match a particular query sequence. A variety of known searching algorithms are incorporated into commercially available software for conducting homology searches of databases and computer readable media comprising sequences of molecules of the present invention.
- Sequence length of a query sequence may be from about 10 to about 100 or more amino acid residues or from about 20 to about 300 or more nucleotide residues.
- Protein motifs include, but are not limited to, enzymatic active sites and signal sequences.
- An amino acid query is converted to all of the nucleic acid sequences that encode that amino acid sequence by a software program, such as TBLASTN, which is then used to search the database.
- Nucleic acid query sequences that are motifs include, but are not limited to, promoter sequences, cis elements, hairpin structures and inducible expression elements (protein binding sequences).
- One embodiment of the invention provides an input device for receiving a query sequence, a memory for storing sequences (the query sequences of the present invention and sequences identified using a homology search as described above), and an output device for outputting the identified homologous sequences.
- a variety of structural formats for the input and output presentations can be used to input and output information in the computer-based systems of the present invention.
- One format for an output presentation ranks fragments of the sequence of the present invention by varying degrees of homology to the query sequence. Such presentation provides a skilled artisan with a ranking of sequences that contain various amounts of the query sequence and identifies the degree of homology contained in the identified fragment.
- a cDNA library is generated from Triticum aestivum tissue. Tissue is harvested and immediately frozen in liquid nitrogen. The harvested tissue is stored at ⁇ 80° C. until preparation of total RNA. The total RNA is purified using Trizol reagent from INVITROGEN Corporation (INVITROGEN Corporation, Carlsbad, Calif., U.S.A.), essentially as recommended by the manufacturer. Poly A+RNA (mRNA) is purified using magnetic oligo dT beads essentially as recommended by the manufacturer (Dynabeads, Dynal Biotech, Oslo, Norway).
- cDNA libraries are well known in the art and a number of cloning strategies exist. A number of cDNA library construction kits are commercially available. cDNA libraries are prepared using the SUPERSCRIPT Plasmid System for cDNA synthesis and Plasmid Cloning (INVITROGEN Corporation, Carlsbad, Calif., U.S.A.), as described in the SUPERSCRIPT II cDNA library synthesis protocol. The cDNA libraries are quality controlled for a good insert:vector ratio.
- the cDNA libraries are plated on LB agar containing the appropriate antibiotics for selection and incubated at 37° for a sufficient time to allow the growth of individual colonies. Single colonies are individually placed in each well of a 96-well microtiter plates containing LB liquid including the selective antibiotics. The plates are incubated overnight at approximately 37° C. with gentle shaking to promote growth of the cultures.
- the plasmid DNA is isolated from each clone using QIAPREP plasmid isolation kits, using the conditions recommended by the manufacturer (QIAGEN Inc., Valencia, Calif. U.S.A.).
- sequences of recombinant polynucleotides may be obtained by a number of sequencing techniques known in the art, including fluorescence-based sequencing methodologies. These methods have the detection, automation, and instrumentation capability necessary for the analysis of large volumes of sequence data. With these types of automated systems, fluorescent dye-labeled sequence reaction products are detected and data entered directly into the computer, producing a chromatogram that is subsequently viewed, stored, and analyzed using the corresponding software programs. These methods are known to those of skill in the art and have been described and reviewed.
- the open reading frame in each recombinant polynucleotide sequence is identified by a combination of predictive and homology based methods.
- the longest open reading frame (ORF) is determined, and the top BLAST match is identified by BLASTX against NCBI.
- the top BLAST hit is then compared to the predicted ORF, with the BLAST hit given precedence in the case of discrepancies.
- Functions of polypeptides encoded by the polynucleotide sequences of the present invention are determined using a hierarchical classification tool, termed FunCAT, for Functional Categories Annotation Tool. Most categories collected in FunCAT are classified by function, although other criteria are used, for example, cellular localization or temporal process. The assignment of a functional category to a query sequence is based on BLASTX sequence search results, which compare two protein sequences. FunCAT assigns categories by iteratively scanning through all blast hits, starting with the most significant match, and reporting the first category assignment for each FunCAT source classification scheme.
- function of a query polypeptide is inferred from the function of a protein homolog where either (1) hit_p ⁇ 1e-30 or % identity>35% AND query_coverage>50% AND hit_coverage>50%, or (2) hit_p ⁇ 1e-8 AND query_coverage>70% AND hit_coverage>70%.
- the column under the heading “CAT_DESC” provides the name of the subcategory into which the query sequence was classified.
- the column under the heading “PRODUCT_HIT_DESC” provides a description of the BLAST hit to the query sequences that led to the specific classification.
- the column under the heading “HIT_E” provides the e-value for the BLAST hit. It is noted that the e-value in the HIT_E column may differ from the e-value based on the top BLAST hit provided in the E_VALUE column since these calculations were done on different days, and database size is an element in E-value calculations. E-values obtained by BLASTing against public databases, such as GenBank, will generally increase over time for any given query/entry match.
- Plant yield may be improved by alteration of a variety of plant pathways, including those involving nitrogen, carbohydrate, or phosphorus utilization and/or uptake. Plant yield may also be improved by alteration of a plant's photosynthetic capacity or by improving a plant's ability to tolerate a variety of environmental stresses, including cold, heat, drought and osmotic stresses.
- sequences of the present invention include pathogen or pest tolerance, herbicide tolerance, disease resistance, growth rate (for example by modification of cell cycle, by expression of transcription factors, or expression of growth regulators), seed oil and/or protein yield and quality, rate and control of recombination, and lignin content.
- Sequences of recombinant polynucleotides are provided herein as SEQ ID NO: 1 through SEQ ID NO: 105,582 and sequences of recombinant polypeptides are provided as SEQ ID NO: 105,583 through SEQ ID NO: 211,164. Descriptions of each of these recombinant polynucleotide and recombinant polypeptide sequences are provided in Table 1 from U.S. Pub. No. 2007/0044171.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Physiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Environmental Sciences (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Recombinant polynucleotides and recombinant polypeptides useful for improvement of plants are provided. The disclosed recombinant polynucleotides and recombinant polypeptides find use in production of transgenic plants to produce plants having improved properties.
Description
- This is a divisional of U.S. application Ser. No. 10/703,032 filed Nov. 6, 2003, and published on Feb. 22, 2007 as U.S. Pub. No. 2007/0044171 A1, which is a continuation-in-part of U.S. application Ser. No. 10/020,338 filed Dec. 12, 2001, which claims the benefit of U.S. Provisional Application No. 60/255,575 filed Dec. 14, 2000, all of which are hereby incorporated by reference in their entireties.
- Two copies of the sequence listing (Sequence Listing Copy 1 and Sequence Listing Copy 2) and a computer-readable form of the sequence listing, all on CD-Rs, each containing the file named pa—00608.rpt, which is 235,202,560 bytes (measured in MS-DOS) and was created on Nov. 3, 2003, are hereby incorporated by reference.
- Disclosed herein are inventions in the field of plant biochemistry and genetics. More specifically recombinant polynucleotides and recombinant polypeptides from Triticum aestivum for use in plant improvement are provided. Methods of using the recombinant polynucleotides and recombinant polypeptides for production of transgenic plants with improved biological characteristics are disclosed.
- The ability to develop transgenic plants with improved traits depends in part on the identification of polynucleotides that are useful for the production of transformed plants having desirable qualities. In this regard, the discovery of polynucleotide sequences of genes, and the polypeptides encoded by such genes, is needed. Molecules comprising such polynucleotides may be used, for example, in recombinant DNA constructs useful for imparting unique genetic properties into transgenic plants.
- The present invention provides a recombinant polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582. The present invention also provides a recombinant polypeptide selected from the group consisting of SEQ ID NO: 105,583 through SEQ ID NO: 211,164.
- The present invention also provides a method of producing a plant having an improved property, wherein said method comprises transforming a plant with a recombinant construct comprising a promoter region functional in a plant cell operably joined to a polynucleotide comprising a coding sequence for a polypeptide associated with said property, and growing said transformed plant.
- The present invention provides recombinant polynucleotides and recombinant polypeptides from Triticum aestivum. The recombinant polynucleotides and recombinant polypeptides of the present invention find a number of uses, for example in recombinant DNA constructs, in physical arrays of molecules, for use as plant breeding markers, and for use in computer based storage and analysis systems.
- The recombinant polynucleotides of the present invention also find use in generation of transgenic plants to provide for increased or decreased expression of the polypeptides encoded by the recombinant polynucleotides provided herein. As used herein a “transgenic” organism is one whose genome has been altered by the incorporation of foreign genetic material or additional copies of native genetic material, e.g. by transformation or recombination. As a result of such biotechnological applications, plants, particularly crop plants, having improved properties are obtained. Crop plants of interest in the present invention include, but are not limited to soy, cotton, canola, maize, wheat, sunflower, sorghum, alfalfa, barley, millet, rice, tobacco, fruit and vegetable crops, and turf grass. In one embodiment the disclosed recombinant polynucleotides provide plants having improved yield resulting from improved utilization of key biochemical compounds, such as nitrogen, phosphorous and carbohydrate, or resulting from improved responses to environmental stresses, such as cold, heat, drought, salt, and attack by pests or pathogens. Recombinant polynucleotides of the present invention may be used to provide plants having improved growth and development, and ultimately increased yield, as the result of modified expression of plant growth regulators or modification of cell cycle or photosynthesis pathways. Other traits of interest that may be modified in plants using polynucleotides of the present invention include flavonoid content, seed oil and protein quantity and quality, herbicide tolerance, and rate of homologous recombination.
- Depending on the intended use, the recombinant polynucleotides of the present invention may be present in the form of DNA, such as cDNA or genomic DNA, or as RNA, for example mRNA. The polynucleotides of the present invention may be single or double stranded and may represent the coding, or sense strand of a gene, or the non-coding, antisense, strand. In one embodiment, the recombinant polynucleotides of this invention represent cDNA sequences from Triticum aestivum. DNA sequences representing the recombinant polynucleotides are provided herein as SEQ ID NO: 1 through SEQ ID NO: 105,582.
- The term “recombinant polynucleotide” as used herein refers to a polynucleotide produced by recombinant DNA technology. In one embodiment a recombinant polynucleotide may be produced by separation from substantially all other molecules normally associated with it in its native state. A recombinant polynucleotide may be greater than 60% free, greater than 75% free, greater than 90% free, or greater than 95% free from the other molecules (exclusive of solvent) present in the natural mixture. In another embodiment, a recombinant polynucleotide may be separated from nucleic acids which normally flank the polynucleotide in nature. Thus, polynucleotides fused to regulatory or coding sequences with which they are not normally associated, for example as the result of recombinant techniques, are considered recombinant polynucleotides herein. Such molecules are considered recombinant polynucleotides even when present, for example in the chromosome of a host cell, or in a nucleic acid solution. The term recombinant polynucleotide as used herein is not intended to encompass molecules present in their native state.
- It is understood that the molecules of the invention may be labeled with reagents that facilitate detection of the molecule. As used herein, a label can be any reagent that facilitates detection, including fluorescent labels, chemical labels, or modified bases, including nucleotides with radioactive elements, e.g. 32P, 33P, 35S or 125I such as 32P deoxycytidine-5′-triphosphate (32PdCTP).
- Recombinant polynucleotides of the present invention are capable of specifically hybridizing to other polynucleotides under certain circumstances. As used herein, two polynucleotides are said to be capable of specifically hybridizing to one another if the two molecules are capable of forming an anti-parallel, double-stranded nucleic acid structure. A polynucleotide is said to be the “complement” of another polynucleotide if the molecules exhibit complete complementarity. As used herein, molecules are said to exhibit “complete complementarity” when every nucleotide in each of the polynucleotides is complementary to the corresponding nucleotide of the other. Two polynucleotides are said to be “minimally complementary” if they can hybridize to one another with sufficient stability to permit them to remain annealed to one another under at least conventional “low-stringency” conditions. Similarly, the polynucleotides are said to be “complementary” if they can hybridize to one another with sufficient stability to permit them to remain annealed to one another under conventional “high-stringency” conditions. Conventional stringency conditions are known to those skilled in the art and can be found, for example in Molecular Cloning: A Laboratory Manual, 3rd edition Volumes 1, 2, and 3. J. F. Sambrook, D. W. Russell, and N. Irwin, Cold Spring Harbor Laboratory Press, 2000.
- Departures from complete complementarity are therefore permissible, as long as such departures do not completely preclude the capacity of the polynucleotides to form a double-stranded structure. Thus, in order for a polynucleotide to serve as a primer or probe it need only be sufficiently complementary in sequence to be able to form a stable double-stranded structure under the particular solvent and salt concentrations employed. Appropriate stringency conditions which promote DNA hybridization are, for example, 6.0× sodium chloride/sodium citrate (SSC) at about 45° C., followed by a wash of 2.0×SSC at 50° C. Such conditions are known to those skilled in the art and can be found, for example in Current Protocols in Molecular Biology, John Wiley & Sons, N.Y. (1989). Salt concentration and temperature in the wash step can be adjusted to alter hybridization stringency. For example, conditions may vary from low stringency of about 2.0×SSC at 40° C. to moderately stringent conditions of about 2.0×SSC at 50° C. to high stringency conditions of about 0.2×SSC at 50° C.
- As used herein “sequence identity” refers to the extent to which two optimally aligned polynucleotides or polypeptide sequences are invariant throughout a window of alignment of components, e.g. nucleotides or amino acids. An “identity fraction” for aligned segments of a test sequence and a reference sequence is the number of identical components which are shared by the two aligned sequences divided by the total number of components in the reference sequence segment, i.e. the entire reference sequence or a smaller defined part of the reference sequence. “Percent identity” is the identity fraction times 100. Comparison of sequences to determine percent identity can be accomplished by a number of well-known methods, including for example by using mathematical algorithms, such as those in the BLAST suite of sequence analysis programs.
- In one embodiment this invention provides recombinant polynucleotides comprising regions that encode polypeptides. The encoded polypeptides may be the complete protein encoded by the gene represented by the polynucleotide, or may be fragments of the encoded protein. In one embodiment, polynucleotides provided herein encode polypeptides constituting a substantial portion of the complete protein. In another embodiment polynucleotides provided herein encode polypeptides constituting a sufficient portion of the complete protein to provide the relevant biological activity.
- In one embodiment recombinant polynucleotides of the present invention encode polypeptides involved in one or more important biological function in plants. Such recombinant polynucleotides may be expressed in transgenic plants to produce plants having improved phenotypic properties and/or improved response to stressful environmental conditions. See, for example, Table 1 in U.S. Pub. No. 2007/0044171 (the contents of this published patent application and the table therein are incorporated in their entireties, by reference) for a list of SEQ ID numbers representing the recombinant polynucleotides that may be expressed in transgenic plants to impart an improved plant property where improved plant properties are provided for each sequence in the PRODUCT_CAT_DESC column.
- Recombinant polynucleotides of the present invention are generally used to impart such improved properties by providing for enhanced protein activity in a transgenic organism, such as a transgenic plant, although in some cases, improved properties are obtained by providing for reduced protein activity in a transgenic plant. Reduced protein activity and enhanced protein activity are measured by reference to a wild type cell or organism and can be determined by direct or indirect measurement. Direct measurement of protein activity might include an analytical assay for the protein, per se, or enzymatic product of protein activity. Indirect assay might include measurement of a property affected by the protein. Enhanced protein activity can be achieved in a number of ways, for example by overproduction of mRNA encoding the protein or by gene shuffling. One skilled in the art will know methods to achieve overproduction of mRNA, for example by providing increased recombinant copies of a gene or by introducing a recombinant construct having a heterologous promoter operably linked to a recombinant polynucleotide encoding a polypeptide into a target cell or organism. Reduced protein activity can be achieved by a variety of mechanisms including antisense, mutation, or knockout. Antisense RNA will reduce the level of expressed protein resulting in reduced protein activity as compared to wild type activity levels. A mutation in the gene encoding a protein may reduce the level of expressed protein and/or interfere with the function of expressed protein to cause reduced protein activity.
- In one embodiment, the invention is a fragment of a disclosed recombinant polynucleotide consisting of oligonucleotides of at least 15, at least 16 or 17, at least 18 or 19, or at least 20 or more consecutive nucleotides. Such oligonucleotides are fragments of the larger recombinant polynucleotides having a sequence selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, and find use, for example as probes and primers for detection of the polynucleotides of the present invention.
- In one embodiment the present invention is a functional variant of a recombinant polynucleotide provided herein. As used herein, a “functional variant” refers to any second polynucleotide varying from a first polynucleotide sequence in such a way so as not to significantly affect the function when compared to the function of the first polynucleotide. Such functional variants may be naturally occurring, including homologous polynucleotides from the same or a different species, or may be non-natural functional variants, for example polynucleotides synthesized using chemical synthesis methods, or generated using recombinant DNA techniques. With respect to nucleotide sequences, degeneracy of the genetic code provides the possibility to substitute at least one base of the protein encoding sequence of a gene with a different base without causing the amino acid sequence of the polypeptide produced from the gene to be changed. Hence, in one embodiment, a recombinant polynucleotide of the present invention may have any base sequence that has been changed from SEQ ID NO: 1 through SEQ ID NO: 105,582 by substitution in accordance with degeneracy of the genetic code. See for example, U.S. Pat. No. 5,500,365, which is hereby incorporated by reference.
- Polynucleotides of the present invention that are functional variants of the polynucleotides provided herein will generally demonstrate significant identity with the polynucleotides provided herein. Of particular interest are polynucleotide homologs having at least about 60% sequence identity, at least about 70% sequence identity, at least about 80% sequence identity, at least about 85% sequence identity, and at least about 90%, 95% or even greater, such as 98% or 99% sequence identity with polynucleotide sequences described herein.
- In one embodiment this invention also provides recombinant polypeptides. Amino acid sequences of the recombinant polypeptides of the present invention are provided herein as SEQ ID NO: 105,583 through SEQ ID NO: 211,164.
- As used herein, the term “polypeptide” refers to an unbranched chain of amino acid residues that are covalently linked by an amide linkage between the carboxyl group of one amino acid and the amino group of another. The term polypeptide can encompass whole proteins (i.e. a functional protein encoded by a particular gene), as well as fragments of proteins. In one embodiment the invention is a recombinant polypeptide which represents a whole protein. In another embodiment the invention is a recombinant polypeptide which represents a sufficient portion of an entire protein to impart the relevant biological activity of the protein. The term “protein” also includes molecules consisting of one or more polypeptide chains. Thus, a recombinant polypeptide of the present invention may also constitute an entire gene product, but only a portion of a functional oligomeric protein having multiple polypeptide chains.
- As used herein, the term “recombinant polypeptide” refers to a polypeptide produced as a result of recombinant DNA technology. The term recombinant polypeptide as used herein is not intended to encompass molecules present in their native state.
- In one embodiment the invention is a recombinant polypeptide involved in one or more important biological properties in a plant. Such recombinant polypeptide may be produced in transgenic plants to provide plants having improved phenotypic properties and/or improved response to stressful environmental conditions. In some cases, decreased expression of such polypeptide may be desired, such decreased expression being obtained by use of the polynucleotide sequences provided herein, for example in antisense or cosuppression methods. See, Table 1 from U.S. Pub. No. 2007/0044171 for a list of improved plant properties and PROTEIN_NUM for the recombinant polypeptide whose expression may be altered in transgenic plants to impart such improvements. A summary of such improved properties and polypeptides of interest for increased or decreased expression is provided below.
- Yield/Nitrogen: Yield improvement by improved nitrogen flow, sensing, uptake, storage and/or transport. Polypeptides useful for imparting such properties include those involved in aspartate and glutamate biosynthesis, polypeptides involved in aspartate and glutamate transport, polypeptides associated with the TOR (Target of Rapamycin) pathway, nitrate transporters, ammonium transporters, chlorate transporters and polypeptides involved in tetrapyrrole biosynthesis.
- Yield/Carbohydrate: Yield improvement by effects on carbohydrate metabolism, for example by increased sucrose production and/or transport. Polypeptides useful for improved yield by effects on carbohydrate metabolism include polypeptides involved in sucrose or starch metabolism, carbon assimilation or carbohydrate transport, including, for example sucrose transporters or glucose/hexose transporters, enzymes involved in glycolysis/gluconeogenesis, the pentose phosphate cycle, or raffinose biosynthesis, and polypeptides involved in glucose signaling, such as SNF1 complex proteins.
- Yield/Photosynthesis: Yield improvement resulting from increased photosynthesis. Polypeptides useful for increasing the rate of photosynthesis include phytochrome, photosystem I and II proteins, electron carriers, ATP synthase, NADH dehydrogenase and cytochrome oxidase.
- Yield/Phosphorus: Yield improvement resulting from increased phosphorus uptake, transport or utilization. Polypeptides useful for improving yield in this manner include phosphatases and phosphate transporters.
- Yield/Stress tolerance: Yield improvement resulting from improved plant growth and development by helping plants to tolerate stressful growth conditions. Polypeptides useful for improved stress tolerance under a variety of stress conditions include polypeptides involved in gene regulation, such as serine/threonine-protein kinases, MAP kinases, MAP kinase kinases, and MAP kinase kinases; polypeptides that act as receptors for signal transduction and regulation, such as receptor protein kinases; intracellular signaling proteins, such as protein phosphatases, GTP binding proteins, and phospholipid signaling proteins; polypeptides involved in arginine biosynthesis; polypeptides involved in ATP metabolism, including for example ATPase, adenylate transporters, and polypeptides involved in ATP synthesis and transport; polypeptides involved in glycine betaine, jasmonic acid, flavonoid or steroid biosynthesis; and hemoglobin. Enhanced or reduced activity of such polypeptides in transgenic plants will provide changes in the ability of a plant to respond to a variety of environmental stresses, such as chemical stress, drought stress and pest stress.
- Cold tolerance: Polypeptides of interest for improving plant tolerance to cold or freezing temperatures include polypeptides involved in biosynthesis of trehalose or raffinose, polypeptides encoded by cold induced genes, fatty acyl desaturases and other polypeptides involved in glycerolipid or membrane lipid biosynthesis, which find use in modification of membrane fatty acid composition, alternative oxidase, calcium-dependent protein kinases, LEA proteins and uncoupling protein.
- Heat tolerance: Polypeptides of interest for improving plant tolerance to heat include polypeptides involved in biosynthesis of trehalose, polypeptides involved in glycerolipid biosynthesis or membrane lipid metabolism (for altering membrane fatty acid composition), heat shock proteins and mitochondrial NDK.
- Osmotic tolerance: Polypeptides of interest for improving plant tolerance to extreme osmotic, conditions include polypeptides involved in proline biosynthesis.
- Drought tolerance: Polypeptides of interest for improving plant tolerance to drought conditions include aquaporins, polypeptides involved in biosynthesis of trehalose or wax, LEA proteins and invertase.
- Pathogen or pest tolerance: Polypeptides of interest for improving plant tolerance to effects of plant pests or pathogens include proteases, polypeptides involved in anthocyanin biosynthesis, polypeptides involved in cell wall metabolism, including cellulases, glucosidases, pectin methylesterase, pectinase, polygalacturonase, chitinase, chitosanase, and cellulose synthase, and polypeptides involved in biosynthesis of terpenoids or indole for production of bioactive metabolites to provide defense against herbivorous insects.
- Cell cycle modification: Polypeptides encoding cell cycle enzymes and regulators of the cell cycle pathway are useful for manipulating growth rate in plants to provide early vigor and accelerated maturation leading to improved yield. Improvements in quality traits, such as seed oil content, may also be obtained by expression of cell cycle enzymes and cell cycle regulators. Polypeptides of interest for modification of cell cycle pathway include cyclins and EIF5alpha pathway proteins, polypeptides involved in polyamine metabolism, polypeptides which act as regulators of the cell cycle pathway, including cyclin-dependent kinases (CDKs), CDK-activating kinases, CDK-inhibitors, Rb and Rb-binding proteins, and transcription factors that activate genes involved in cell proliferation and division, such as the E2F family of transcription factors, proteins involved in degradation of cyclins, such as cullins, and plant homologs of tumor suppressor polypeptides.
- Seed protein yield/content: Polypeptides useful for providing increased seed protein quantity and/or quality include polypeptides involved in the metabolism of amino acids in plants, particularly polypeptides involved in biosynthesis of methionine/cysteine and lysine, amino acid transporters, amino acid efflux carriers, seed storage proteins, proteases, and polypeptides involved in phytic acid metabolism.
- Seed oil yield/content: Polypeptides useful for providing increased seed oil quantity and/or quality include polypeptides involved in fatty acid and glycerolipid biosynthesis, beta-oxidation enzymes, enzymes involved in biosynthesis of nutritional compounds, such as carotenoids and tocopherols, and polypeptides that increase embryo size or number or thickness of aleurone.
- Disease response in plants: Polypeptides useful for imparting improved disease responses to plants include polypeptides encoded by cercosporin induced genes, antifungal proteins and proteins encoded by R-genes or SAR genes. Expression of such polypeptides in transgenic plants will provide an increase in disease resistance ability of plants.
- Galactomannanan biosynthesis: Polypeptides involved in production of galactomannans are of interest for providing plants having increased and/or modified reserve polysaccharides for use in food, pharmaceutical, cosmetic, paper and paint industries.
- Flavonoid/isoflavonoid metabolism in plants: Polypeptides of interest for modification of flavonoid/isoflavonoid metabolism in plants include cinnamate-4-hydroxylase, chalcone synthase and flavonol synthase. Enhanced or reduced activity of such polypeptides in transgenic plants will provide changes in the quantity and/or speed of flavonoid metabolism in plants and may improve disease resistance by enhancing synthesis of protective secondary metabolites or improving signaling pathways governing disease resistance.
- Plant growth regulators: Polypeptides involved in production of substances that regulate the growth of various plant tissues are of interest in the present invention and may be used to provide transgenic plants having altered morphologies and improved plant growth and development profiles leading to improvements in yield and stress response. Of particular interest are polypeptides involved in the biosynthesis of plant growth hormones, such as gibberellins, cytokinins, auxins, ethylene and abscisic acid, and other proteins involved in the activity and/or transport of such polypeptides, including for example, cytokinin oxidase, cytokinin/purine permeases, F-box proteins, G-proteins and phytosulfokines.
- Herbicide tolerance: Polypeptides of interest for producing plants having tolerance to plant herbicides include polypeptides involved in the shikimate pathway, which are of interest for providing glyphosate tolerant plants. Such polypeptides include polypeptides involved in biosynthesis of chorismate, phenylalanine, tyrosine and tryptophan.
- Transcription factors in plants: Transcription factors play a key role in plant growth and development by controlling the expression of one or more genes in temporal, spatial and physiological specific patterns. Enhanced or reduced activity of such polypeptides in transgenic plants will provide significant changes in gene transcription patterns and provide a variety of beneficial effects in plant growth, development and response to environmental conditions. Transcription factors of interest include, but are not limited to myb transcription factors, including helix-turn-helix proteins, homeodomain transcription factors, leucine zipper transcription factors, MADS transcription factors, transcription factors having AP2 domains, zinc finger transcription factors, CCAAT binding transcription factors, ethylene responsive transcription factors, transcription initiation factors and UV damaged DNA binding proteins.
- Homologous recombination: Increasing the rate of homologous recombination in plants is useful for accelerating the introgression of transgenes into breeding varieties by backcrossing, and to enhance the conventional breeding process by allowing rare recombinants between closely linked genes in phase repulsion to be identified more easily. Polypeptides useful for expression in plants to provide increased homologous recombination include polypeptides involved in mitosis and/or meiosis, including for example, resolvases and polypeptide members of the RAD52 epistasis group. Lignin biosynthesis: Polypeptides involved in lignin biosynthesis are of interest for increasing plants' resistance to lodging and for increasing the usefulness of plant materials as biofuels.
- In one embodiment of the invention, the function of a recombinant polypeptide is determined by comparison of the amino acid sequence of the recombinant polypeptide to amino acid sequences of known polypeptides. A variety of homology based search algorithms are available to compare a query sequence to a protein database, including for example, BLAST, FASTA, and Smith-Waterman. In the present application, BLASTX and BLASTP algorithms are used to provide protein function information. A number of values are examined in order to assess the confidence of the function assignment. Useful measurements include “E-value” (also shown as “hit_p”), “percent identity”, “percent query coverage”, and “percent hit coverage”.
- In BLAST, E-value, or expectation value, represents the number of different alignments with scores equivalent to or better than the raw alignment score, S, that are expected to occur in a database search by chance. The lower the E value, the more significant the match. Because database size is an element in E-value calculations, E-values obtained by BLASTing against public databases, such as GENBANK, have generally increased over time for any given query/entry match. In setting criteria for confidence of polypeptide function prediction, a “high” BLAST match is considered herein as having an E-value for the top BLAST hit provided in Table 1 from U.S. Pub. No. 2007/0044171 of less than 1E-30; a medium BLASTX E-value is 1E-30 to 1E-8; and a low BLASTX E-value is greater than 1E-8. The top BLAST hit and corresponding E values are provided in Table 1 from U.S. Pub. No. 2007/0044171.
- Percent identity refers to the percentage of identically matched amino acid residues that exist along the length of that portion of the sequences which is aligned by the BLAST algorithm. In setting criteria for confidence of polypeptide function prediction, a “high” BLAST match is considered herein as having percent identity for the top BLAST hit provided in Table 1 from U.S. Pub. No. 2007/0044171 of at least 70%; a medium percent identity value is 35% to 70%; and a low percent identity is less than 35%.
- In one embodiment of the invention, the protein function assignment in the present invention is determined using combinations of E-values, percent identity, query coverage and hit coverage. Query coverage refers to the percent of the query sequence that is represented in the BLAST alignment. Hit coverage refers to the percent of the database entry that is represented in the BLAST alignment. In one embodiment of the invention, function of a query polypeptide is inferred from function of a protein homolog where either (1) hit_p<1e-30 or % identity>35% AND query_coverage>50% AND hit_coverage>50%, or (2) hit_p<1e-8 AND query_coverage>70% AND hit_coverage>70%.
- Another aspect of the invention comprises a functional variant which differs in one or more amino acids from those of a recombinant polypeptide provided herein as the result of one or more conservative amino acid substitutions. It is well known in the art that one or more amino acids in a reference sequence can be substituted with at least one other amino acid, the charge and polarity of which are similar to that of the native amino acid, resulting in a silent change. For instance, valine is a conservative substitute for alanine and threonine is a conservative substitute for serine. Conservative substitutions for an amino acid within a polypeptide sequence can be selected from other members of the class to which the naturally occurring amino acid belongs. Amino acids can be divided into the following four groups: (1) acidic amino acids, (2) basic amino acids, (3) neutral polar amino acids, and (4) neutral nonpolar amino acids. Representative amino acids within these various groups include, but are not limited to: (1) acidic (negatively charged) amino acids such as aspartic acid and glutamic acid; (2) basic (positively charged) amino acids such as arginine, histidine, and lysine; (3) neutral polar amino acids such as glycine, serine, threonine, cysteine, tyrosine, asparagine, and glutamine; and (4) neutral nonpolar (hydrophobic) amino acids such as alanine, leucine, isoleucine, valine, proline, phenylalanine, tryptophan, and methionine. Conserved substitutes for an amino acid within a polypeptide sequence can be selected from other members of the group to which the naturally occurring amino acid belongs. For example, a group of amino acids having aliphatic side chains is glycine, alanine, valine, leucine, and isoleucine; a group of amino acids having aliphatic-hydroxyl side chains is serine and threonine; a group of amino acids having amide-containing side chains is asparagine and glutamine; a group of amino acids having aromatic side chains is phenylalanine, tyrosine, and tryptophan; a group of amino acids having basic side chains is lysine, arginine, and histidine; and a group of amino acids having sulfur-containing side chains is cysteine and methionine. Examples of conservative amino acid substitution groups are: valine-leucine, valine-isoleucine, phenylalanine-tyrosine, lysine-arginine, alanine-valine, aspartic acid-glutamic acid, and asparagine-glutamine. In one embodiment a recombinant polypeptide of the invention may differ in one or more amino acids as the result of deletion or insertion of one or more amino acids in a native sequence. See for example, U.S. Pat. No. 5,500,365, which is hereby incorporated by reference.
- One embodiment of the present invention is a variant which has the same function as a recombinant polypeptide provided herein, but with increased or decreased activity or altered specificity. Such variations in protein activity can be achieved by mutagenesis or may exist naturally in polypeptides encoded by related genes, for example in a related polypeptide encoded by a different allele or in a different species. Variant polypeptides may be obtained by well known nucleic acid or protein screening methods using DNA or antibody probes, for example by screening libraries for genes encoding related polypeptides, or in the case of expression libraries, by screening directly for variant polypeptides. Screening methods for obtaining a modified protein or enzymatic activity of interest by mutagenesis are disclosed in U.S. Pat. No. 5,939,250, which is hereby incorporated by reference. An alternative approach to the generation of variants uses random recombination techniques such as “DNA shuffling” as disclosed in U.S. Pat. Nos. 5,605,793; 5,811,238; 5,830,721 and 5,837,458; and International Applications WO 98/31837 and WO 99/65927, all of which are hereby incorporated by reference. An alternative method of molecular evolution involves a staggered extension process (StEP) for in vitro mutagenesis and recombination of nucleic acid molecule sequences, as disclosed in U.S. Pat. No. 5,965,408 and International Application WO 98/42832, both of which are hereby incorporated by reference.
- Polypeptides of the present invention that are functional variants of the polypeptides provided herein will generally demonstrate significant identity with the polypeptides provided herein. One embodiment of the invention is a polypeptide having at least about 35% sequence identity, at least about 50% sequence identity, at least about 60% sequence identity, at least about 70% sequence identity, at least about 80% sequence identity, and at least about 85%, 90%, 95% or even greater sequence identity with a recombinant polypeptide sequence described herein. One embodiment of the invention is a polypeptide having an amino acid sequence provided herein (reference polypeptides) and functional variants of such reference polypeptide, wherein such functional variant comprises at least about 50 consecutive amino acids having at least about 90% identity to about a 50 amino acid polypeptide fragment of said reference polypeptide.
- In one embodiment the invention encompasses the use of recombinant polynucleotides in recombinant constructs, i.e. constructs comprising recombinant polynucleotides that are constructed or modified outside of cells and that join nucleic acids that are not found joined in nature. Using methods known to those of ordinary skill in the art, recombinant polynucleotides of the invention can be inserted into recombinant DNA constructs that can then be introduced into a host cell of choice for expression of the encoded polypeptide or to provide for reduction of expression of the encoded polypeptide, for example by antisense or cosuppression methods. Potential host cells include both prokaryotic and eukaryotic cells. One embodiment of the invention uses a recombinant polynucleotide of the present invention for preparation of recombinant constructs for use in plant transformation.
- In plant transformation, exogenous genetic material is transferred into a plant cell. As used herein “exogenous” refers to a nucleic acid molecule, for example a recombinant DNA construct comprising a recombinant polynucleotide of the present invention, produced outside the organism, e.g. plant, into which it is introduced. An exogenous nucleic acid molecule can have a naturally occurring or non-naturally occurring nucleic acid sequence. One skilled in the art recognizes that an exogenous nucleic acid molecule can be derived from the same species into which it is introduced or from a different species. Such exogenous genetic material may be transferred into either monocot or dicot plants including, but not limited to, soy, cotton, canola, maize, teosinte, wheat, rice, and Arabidopsis plants. Transformed plant cells comprising such exogenous genetic material may be regenerated to produce whole transformed plants.
- Exogenous genetic material may be transferred into a plant cell by the use of a recombinant construct, also known as a vector, designed for such a purpose. A recombinant construct can comprise a number of sequence elements, including promoters, encoding regions, and selectable markers. Recombinant constructs are available which have been designed to replicate in both E. coli and A. tumefaciens and have all of the features required for transferring large inserts of DNA into plant chromosomes. Design of such vectors is generally within the skill of the art.
- A recombinant construct will generally include a plant promoter to direct transcription of the protein-encoding region or the antisense sequence of choice. Numerous promoters, which are active in plant cells, have been described in the literature. These include the nopaline synthase (NOS) promoter and octopine synthase (OCS) promoters carried on tumor-inducing plasmids of Agrobacterium tumefaciens or caulimovirus promoters such as the Cauliflower Mosaic Virus (CaMV) 19S or 35S promoter (U.S. Pat. No. 5,352,605), and the Figwort Mosaic Virus (FMV) 35S-promoter (U.S. Pat. No. 5,378,619). These promoters and numerous others have been used to create recombinant vectors for expression in plants. Any promoter known or found to cause transcription of DNA in plant cells can be used in the present invention. Other useful promoters are described, for example, in U.S. Pat. Nos. 5,378,619; 5,391,725; 5,428,147; 5,447,858; 5,608,144; 5,614,399; 5,633,441; and 5,633,435, all of which are hereby incorporated by reference.
- In addition, promoter enhancers, such as the CaMV 35S enhancer or a tissue specific enhancer, may be used to enhance gene transcription levels. Enhancers often are found 5′ to the start of transcription in a promoter that functions in eukaryotic cells, but can often be inserted in the forward or reverse orientation 5′ or 3′ to the coding sequence. In some instances, these 5′ enhancing elements are introns. Deemed to be particularly useful as enhancers are the 5′ introns of the rice actin 1 and rice actin 2 genes. Examples of other enhancers which could be used in accordance with the invention include elements from octopine synthase genes, the maize alcohol dehydrogenase gene intron 1, elements from the maize shrunken 1 gene, the sucrose synthase intron, the TMV omega element, and promoters from non-plant eukaryotes.
- Recombinant constructs can also contain one or more 5′ non-translated leader sequences which serve to enhance polypeptide production from the resulting mRNA transcripts. Such sequences may be derived from the promoter selected to express the gene or can be specifically modified to increase translation of the mRNA. Such regions may also be obtained from viral RNAs, from suitable eukaryotic genes, or from a synthetic gene sequence. For a review of optimizing expression of transgenes, see Koziel et al. (1996) Plant Mol. Biol. 32:393-405).
- Recombinant constructs may also include, with the coding region of interest, a nucleic acid sequence that acts, in whole or in part, to terminate transcription of that region. One type of 3′ untranslated sequence which may be used is a 3′ UTR from the nopaline synthase gene (nos 3′) of Agrobacterium tumefaciens. Other 3′ termination regions of interest include those from a gene encoding the small subunit of a ribulose-1,5-bisphosphate carboxylase-oxygenase (rbcS), and more specifically, from a rice rbcS gene (U.S. Pat. No. 6,426,446), the 3′ UTR for the T7 transcript of Agrobacterium tumefaciens, the 3′ end of the protease inhibitor I or II genes from potato or tomato, and the 3′ region isolated from Cauliflower Mosaic Virus. Alternatively, one also could use a gamma coixin, oleosin 3 or other 3′ UTRs from the genus Coix (PCT Publication WO 99/58659).
- Recombinant constructs may also include a selectable marker. Selectable markers may be used to select for plants or plant cells that contain the exogenous genetic material. Useful selectable marker genes include those conferring resistance to antibiotics such as kanamycin (nptII), hygromycin B (aph IV) and gentamycin (aac3 and aacC4) or resistance to herbicides such as glufosinate (bar or pat) and glyphosate (EPSPS). Examples of such selectable markers are illustrated in U.S. Pat. Nos. 5,550,318; 5,633,435; 5,780,708 and 6,118,047, all of which are hereby incorporated by reference.
- Recombinant constructs may also include a screenable marker. Screenable markers may be used to monitor transformation. Exemplary screenable markers include genes expressing a colored or fluorescent protein such as a luciferase or green fluorescent protein (GFP), a β-glucuronidase or uidA gene (GUS) which encodes an enzyme for which various chromogenic substrates are known or an R-locus gene, which encodes a product that regulates the production of anthocyanin pigments (red color) in plant tissues. Other possible selectable and/or screenable marker genes will be apparent to those of skill in the art.
- Recombinant constructs may also include a transit peptide for targeting of a gene target to a plant organelle, particularly to a chloroplast, leucoplast or other plastid organelle, see for example U.S. Pat. No. 5,188,642, which is hereby incorporated by reference.
- For use in Agrobacterium mediated transformation methods, recombinant constructs of the present invention may also include T-DNA border regions flanking the DNA to be inserted into the plant genome to provide for transfer of the DNA into the plant host chromosome as discussed in more detail below. An exemplary plasmid that finds use in such transformation methods is pMON18365, a T-DNA vector that can be used to clone exogenous genes and transfer them into plants using Agrobacterium-mediated transformation. See published U.S. Patent Application 20030024014, which is hereby incorporated by reference. This vector contains the left border and right border sequences necessary for Agrobacterium transformation. The plasmid also has origins of replication for maintaining the plasmid in both E. coli and Agrobacterium tumefaciens strains.
- A candidate gene is prepared for insertion into the T-DNA vector, for example using well-known gene cloning techniques such as PCR. Restriction sites may be introduced onto each end of the gene to facilitate cloning. For example, candidate genes may be amplified by PCR techniques using a set of primers. Both the amplified DNA and the cloning vector are cut with the same restriction enzymes, for example, NotI and PstI. The resulting fragments are gel-purified, ligated together, and transformed into E. coli. Plasmid DNA containing the vector with inserted gene may be isolated from E. coli cells selected for spectinomycin resistance, and the presence of the desired insert verified by digestion with the appropriate restriction enzymes. Undigested plasmid may then be transformed into Agrobacterium tumefaciens using techniques well known to those in the art, and transformed Agrobacterium cells containing the vector of interest selected based on spectinomycin resistance. These and other similar recombinant constructs useful for plant transformation may be readily prepared by one skilled in the art.
- Methods and compositions for transforming bacteria and other microorganisms are known in the art. See for example Molecular Cloning: A Laboratory Manual, 3rd edition Volumes 1, 2, and 3. J. F. Sambrook, D. W. Russell, and N. Irwin, Cold Spring Harbor Laboratory Press, 2000.
- Technology for introduction of DNA into cells is well known to those of skill in the art. Methods and materials for transforming plants by introducing a transgenic DNA construct into a plant genome in the practice of this invention can include any of the well-known and demonstrated methods including electroporation as illustrated in U.S. Pat. No. 5,384,253, microprojectile bombardment as illustrated in U.S. Pat. Nos. 5,015,580; 5,550,318; 5,538,880; 6,160,208; 6,399,861 and 6,403,865, Agrobacterium-mediated transformation as illustrated in U.S. Pat. Nos. 5,635,055; 5,824,877; 5,591,616; 5,981,840 and 6,384,301, and protoplast transformation as illustrated in U.S. Pat. No. 5,508,184, all of which are hereby incorporated by reference.
- Any of the recombinant polynucleotides of the present invention may be introduced into a plant cell in a permanent or transient manner in combination with other genetic elements such as vectors, promoters enhancers etc. Further any of the recombinant polynucleotides of the present invention may be introduced into a plant cell in a manner that allows for production of the polypeptide or fragment thereof encoded by the recombinant polynucleotide in the plant cell, or in a manner that provides for decreased expression of an endogenous gene and concomitant decreased production of protein.
- It is also to be understood that two different transgenic plants can also be mated to produce offspring that contain two independently segregating added, exogenous genes. Selfing of appropriate progeny can produce plants that are homozygous for both added, exogenous genes that encode a polypeptide of interest. Back-crossing to a parental plant and out-crossing with a non-transgenic plant are also contemplated, as is vegetative propagation.
- Expression of the recombinant polynucleotides of the present invention and the concomitant production of polypeptides encoded by the recombinant polynucleotides is of interest for production of transgenic plants having improved properties, particularly, improved properties which result in crop plant yield improvement. Expression of recombinant polypeptides of the present invention in plant cells may be evaluated by specifically identifying the protein products of the introduced genes or evaluating the phenotypic changes brought about by their expression. It is noted that when the polypeptide being produced in a transgenic plant is native to the target plant species, quantitative analyses comparing the transformed plant to wild type plants may be required to demonstrate increased expression of the polypeptide of this invention.
- Assays for the production and identification of specific proteins make use of various physical-chemical, structural, functional, or other properties of the proteins. Unique physical-chemical or structural properties allow the proteins to be separated and identified by electrophoretic procedures, such as native or denaturing gel electrophoresis or isoelectric focusing, or by chromatographic techniques such as ion exchange or gel exclusion chromatography. The unique structures of individual proteins offer opportunities for use of specific antibodies to detect their presence in formats such as an ELISA assay. Combinations of approaches may be employed with even greater specificity such as western blotting in which antibodies are used to locate individual gene products that have been separated by electrophoretic techniques. Additional techniques may be employed to absolutely confirm the identity of the product of interest such as evaluation by amino acid sequencing following purification. Although these are among the most commonly employed, other procedures may be additionally used.
- Assay procedures may also be used to identify the expression of proteins by their functionality, particularly where the expressed protein is an enzyme capable of catalyzing chemical reactions involving specific substrates and products. These reactions may be measured, for example in plant extracts, by providing and quantifying the loss of substrates or the generation of products of the reactions by physical and/or chemical procedures.
- In many cases, the expression of a gene product is determined by evaluating the phenotypic results of its expression. Such evaluations may be simply as visual observations, or may involve assays. Such assays may take many forms including but not limited to analyzing changes in the chemical composition, morphology, or physiological properties of the plant. Chemical composition may be altered by expression of genes encoding enzymes or storage proteins which change amino acid composition and may be detected by amino acid analysis, or by enzymes which change starch quantity which may be analyzed by near infrared reflectance spectrometry. Morphological changes may include greater stature or thicker stalks.
- Plants with decreased expression of a gene of interest can also be achieved through the use of polynucleotides of the present invention, for example by expression of antisense nucleic acids, or by identification of plants transformed with sense expression constructs that exhibit cosuppression effects.
- Antisense approaches are a way of preventing or reducing gene function by targeting the genetic material as disclosed in U.S. Pat. Nos. 4,801,540; 5,107,065; 5,759,829; 5,910,444; 6,184,439; and 6,198,026, all of which are hereby incorporated by reference. The objective of the antisense approach is to use a sequence complementary to the target gene to block its expression and create a mutant cell line or organism in which the level of a single chosen protein is selectively reduced or abolished: Antisense techniques have several advantages over other ‘reverse genetic’ approaches. The site of inactivation and its developmental effect can be manipulated by the choice of promoter for antisense genes or by the timing of external application or microinjection. Antisense can manipulate its specificity by selecting either unique regions of the target gene or regions where it shares homology to other related genes.
- The principle of regulation by antisense RNA is that RNA that is complementary to the target mRNA is introduced into cells, resulting in specific RNA:RNA duplexes being formed by base pairing between the antisense substrate and the target. Under one embodiment, the process involves the introduction and expression of an antisense gene sequence. Such a sequence is one in which part or all of the normal gene sequences are placed under a promoter in inverted orientation so that the ‘wrong’ or complementary strand is transcribed into a noncoding antisense RNA that hybridizes with the target mRNA and interferes with its expression. An antisense vector is constructed by standard procedures and introduced into cells by transformation, transfection, electroporation, microinjection, infection, etc. The type of transformation and choice of vector will determine whether expression is transient or stable. The promoter used for the antisense gene may influence the level, timing, tissue, specificity, or inducibility of the antisense inhibition.
- As used herein “gene suppression” means any of the well-known methods for suppressing expression of protein from a gene including sense suppression, anti-sense suppression and RNAi suppression. In suppressing genes to provide plants with a desirable phenotype, anti-sense and RNAi gene suppression methods are preferred. For a description of anti-sense regulation of gene expression in plant cells see U.S. Pat. No. 5,107,065. For a description of RNAi gene suppression in plants by transcription of a dsRNA see U.S. Pat. No. 6,506,559, U.S. Patent Application Publication No. 2002/0168707 A1, and U.S. patent applications Ser. No. 09/423,143 (see WO 98/53083), 09/127,735 (see WO 99/53050), and 09/084,942 (see WO 99/61631), all of which are hereby incorporated by reference. Suppression of an gene by RNAi can be achieved using a recombinant DNA construct having a promoter operably linked to a DNA element comprising a sense and anti-sense element of a segment of genomic DNA of the gene, e.g., a segment of at least about 23 nucleotides, more preferably about 50 to 200 nucleotides where the sense and anti-sense DNA components can be directly linked or joined by an intron or artificial DNA segment that can form a loop when the transcribed RNA hybridizes to form a hairpin structure. For example, genomic DNA from a polymorphic locus of SEQ ID NO: 1 through SEQ ID NO: 105,582 can be used in a recombinant construct for suppression of a cognate gene by RNAi suppression.
- Insertion mutations created by transposable elements may also prevent gene function. For example, in many dicot plants, transformation with the T-DNA of Agrobacterium may be readily achieved and large numbers of transformants can be rapidly obtained. Also, some species have lines with active transposable elements that can efficiently be used for the generation of large numbers of insertion mutations, while some other species lack such options. Mutant plants produced by Agrobacterium or transposon mutagenesis and having altered expression of a polypeptide of interest can be identified using the polynucleotides of the present invention. For example, a large population of mutated plants may be screened with polynucleotides encoding the polypeptide of interest to detect mutated plants having an insertion in the gene encoding the polypeptide of interest.
- In one embodiment of the invention, polynucleotides of the present invention may be used in site-directed mutagenesis. Site-directed mutagenesis may be utilized to modify nucleic acid sequences, particularly as it is a technique that allows one or more of the amino acids encoded by a nucleic acid molecule to be altered (e.g., a threonine to be replaced by a methionine). Three basic methods for site-directed mutagenesis are often employed. These are cassette mutagenesis, primer extension, and methods based upon PCR.
- In addition to the above discussed procedures, practitioners are familiar with the standard resource materials which describe specific conditions and procedures for the construction, manipulation and isolation of macromolecules (e.g., DNA molecules, plasmids, etc.), generation of recombinant organisms and the screening and isolating of clones.
- In one embodiment of the invention, the recombinant polynucleotides or recombinant polypeptides of this invention may be used to prepare arrays of target molecules arranged on a surface of a substrate. The target molecules may be known molecules, e.g. polynucleotides (including oligonucleotides) or polypeptides, which are capable of binding to specific probes, such as complementary nucleic acids or specific antibodies. The target molecules may be immobilized, e.g. by covalent or non-covalent bonding, to the surface in small amounts of substantially purified and isolated molecules in a grid pattern. By immobilized it is meant that the target molecules maintain their position relative to the solid support under hybridization and washing conditions. Target molecules are deposited in small footprint, isolated quantities of “spotted elements” of preferably single-stranded polynucleotide preferably arranged in rectangular grids in a density of about 30 to 100 or more, e.g. up to about 1000, spotted elements per square centimeter. In one embodiment of the invention, the arrays comprise at least about 100 or more, e.g. at least about 1000 to 5000, distinct target polynucleotides per unit substrate. Where detection of transcription for a large number of genes is desired, the economics of arrays favors a high density design criteria provided that the target molecules are sufficiently separated so that the intensity of the indicia of a binding event associated with highly expressed probe molecules does not overwhelm and mask the indicia of neighboring binding events. For high-density microarrays each spotted element may contain up to about 107 or more copies of the target molecule, e.g. single stranded cDNA, on glass substrates or nylon substrates.
- Arrays of this invention may be prepared with molecules from a single species, preferably a plant species, or with molecules from other species, particularly other plant species. Arrays with target molecules from a single species can be used with probe molecules from the same species or a different species due to the ability of cross species homologous genes to hybridize. It is generally preferred for high stringency hybridization that the target and probe molecules are from the same species.
- In one embodiment of the invention, the organism of interest is a plant and the target molecules are polynucleotides or oligonucleotides with nucleic acid sequences having at least about 80 percent sequence identity to a corresponding sequence of the same length in a recombinant polynucleotide having a sequence selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582 or complements thereof. In another embodiment of the invention, at least about 10% of the target molecules on an array have at least about 15 consecutive nucleotides of sequence having at least about 80% and up to about 100% identity with a corresponding sequence of the same length in a recombinant polynucleotide having a sequence selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582 or complements or fragments thereof.
- Such arrays are useful in a variety of applications, including gene discovery, genomic research, molecular breeding and bioactive compound screening. One use of arrays is in the analysis of differential gene transcription, e.g. transcription profiling where the production of mRNA in different cells, normally a cell of interest and a control, is compared and discrepancies in gene expression are identified. In such assays, the presence of discrepancies indicates a difference in gene expression levels in the cells being compared. Such information is useful for the identification of the types of genes expressed in a particular cell or tissue type in a known environment. Such applications generally involve the following steps: (a) preparation of probe, e.g. attaching a label to a plurality of expressed molecules; (b) contact of probe with the array under conditions sufficient for probe to bind with corresponding target, e.g. by hybridization or specific binding; (c) removal of unbound probe from the array; and (d) detection of bound probe.
- A probe may be prepared with RNA extracted from a given cell line or tissue. The probe may be produced by reverse transcription of mRNA or total RNA and labeled with radioactive or fluorescent labeling. A probe is typically a mixture containing many different sequences in various amounts, corresponding to the numbers of copies of the original mRNA species extracted from the sample.
- The initial RNA sample for probe preparation will typically be derived from a physiological source. The physiological source may be selected from a variety of organisms, with physiological sources of interest including single celled organisms such as yeast and multicellular organisms, including plants and animals, particularly plants, where the physiological sources from multicellular organisms may be derived from particular organs or tissues of the multicellular organism, or from isolated cells derived from an organ, or tissue of the organism. The physiological sources may also be multicellular organisms at different developmental stages (e.g., 10-day-old seedlings), or organisms grown under different environmental conditions (e.g., drought-stressed plants) or treated with chemicals.
- In preparing the RNA probe, the physiological source may be subjected to a number of different processing steps, where such processing steps might include tissue homogenation, cell isolation and cytoplasmic extraction, nucleic acid extraction and the like, where such processing steps are known to the those of skill in the art. Methods of isolating RNA from cells, tissues, organs or whole organisms are well known to those skilled in the art.
- In one embodiment of the invention, the sequence of the molecules of this invention can be provided in a variety of media to facilitate use thereof. Such media may provide a subset thereof in a form that allows a skilled artisan to examine the sequences. In a one embodiment, about 20, about 50, about 100, and about 200 or more of the polynucleotide and/or the polypeptide sequences of the present invention can be recorded on computer readable media. As used herein, “computer readable media” refers to any medium that can be read and accessed directly by a computer. Such media include, but are not limited to: magnetic storage media, such as floppy discs, hard disc, storage medium, and magnetic tape; optical storage media such as CD-ROM; electrical storage media such as RAM and ROM; and hybrids of these categories such as magnetic/optical storage media. A skilled artisan can readily appreciate how any of the presently known computer readable media can be used to create a manufacture comprising a computer readable medium having recorded thereon a nucleotide sequence of the present invention.
- As used herein, “recorded” refers to a process for storing information on computer readable media. A skilled artisan can readily adopt any of the presently known methods for recording information on computer readable media to generate media comprising the nucleotide sequence information of the present invention. A variety of data storage structures are available to a skilled artisan for creating a computer readable medium having recorded thereon a nucleotide sequence of the present invention. The choice of the data storage structure will generally be based on the means chosen to access the stored information. In addition, a variety of data processor programs and formats can be used to store the nucleotide sequence information of the present invention on computer readable media. The sequence information can be represented in a word processing text file, formatted in commercially-available software such as WordPerfect and Microsoft Word, or represented in the form of an ASCII file, stored in a database application, such as DB2, Sybase, Oracle, or the like. A skilled artisan can readily adapt any number of data processor structuring formats (e.g., text file or database) in order to obtain a computer readable medium having recorded thereon the nucleotide sequence information of the present invention.
- By providing one or more of polynucleotide or polypeptide sequences of the present invention in a computer readable medium, a skilled artisan can routinely access the sequence information for a variety of purposes. The examples which follow demonstrate how software which implements the BLAST and BLAZE search algorithms on a Sybase system can be used to identify open reading frames (ORFs) within the genome that contain homology to ORFs or polypeptides from other organisms. Such ORFs are polypeptide encoding fragments within the sequences of the present invention and are useful in producing commercially important polypeptides such as enzymes used in amino acid biosynthesis, metabolism, transcription, translation, RNA processing, nucleic acid and a protein degradation, protein modification, and DNA replication, restriction, modification, recombination, and repair.
- One embodiment of the invention provides systems, particularly computer-based systems, which contain the sequence information described herein. Such systems are designed to identify commercially important fragments of the nucleic acid molecule of the present invention. As used herein, “a computer-based system” refers to the hardware, software, and memory used to analyze the sequence information of the present invention. A skilled artisan can readily appreciate that any one of the currently available computer-based systems are suitable for use in the present invention.
- As indicated above, the computer-based systems of the present invention comprise a database having stored therein a polynucleotide sequence, polypeptide sequence, or both of the present invention and the necessary hardware and software for supporting and implementing a homology search. As used herein, “database” refers to memory system that can store searchable nucleotide sequence information. As used herein “query sequence” is a polynucleotide sequence, or a polypeptide sequence, or a polynucleotide sequence corresponding to a polypeptide sequence, or a polypeptide sequence corresponding to a polynucleotide sequence, that is used to query a collection of polynucleotide or polypeptide sequences. As used herein, “homology search” refers to one or more programs which are implemented on the computer-based system to compare a query sequence, i.e., gene or peptide or a conserved region (motif), with the sequence information stored within the database. Homology searches are used to identify segments and/or regions of the sequence of the present invention that match a particular query sequence. A variety of known searching algorithms are incorporated into commercially available software for conducting homology searches of databases and computer readable media comprising sequences of molecules of the present invention.
- Sequence length of a query sequence may be from about 10 to about 100 or more amino acid residues or from about 20 to about 300 or more nucleotide residues. There are a variety of motifs known in the art. Protein motifs include, but are not limited to, enzymatic active sites and signal sequences. An amino acid query is converted to all of the nucleic acid sequences that encode that amino acid sequence by a software program, such as TBLASTN, which is then used to search the database. Nucleic acid query sequences that are motifs include, but are not limited to, promoter sequences, cis elements, hairpin structures and inducible expression elements (protein binding sequences).
- One embodiment of the invention, provides an input device for receiving a query sequence, a memory for storing sequences (the query sequences of the present invention and sequences identified using a homology search as described above), and an output device for outputting the identified homologous sequences. A variety of structural formats for the input and output presentations can be used to input and output information in the computer-based systems of the present invention. One format for an output presentation ranks fragments of the sequence of the present invention by varying degrees of homology to the query sequence. Such presentation provides a skilled artisan with a ranking of sequences that contain various amounts of the query sequence and identifies the degree of homology contained in the identified fragment.
- Having now generally described the invention, the same will be more readily understood through reference to the following examples which are provided by way of illustration, and are not intended to be limiting of the present invention, unless specified.
- A cDNA library is generated from Triticum aestivum tissue. Tissue is harvested and immediately frozen in liquid nitrogen. The harvested tissue is stored at −80° C. until preparation of total RNA. The total RNA is purified using Trizol reagent from INVITROGEN Corporation (INVITROGEN Corporation, Carlsbad, Calif., U.S.A.), essentially as recommended by the manufacturer. Poly A+RNA (mRNA) is purified using magnetic oligo dT beads essentially as recommended by the manufacturer (Dynabeads, Dynal Biotech, Oslo, Norway).
- Construction of plant cDNA libraries is well known in the art and a number of cloning strategies exist. A number of cDNA library construction kits are commercially available. cDNA libraries are prepared using the SUPERSCRIPT Plasmid System for cDNA synthesis and Plasmid Cloning (INVITROGEN Corporation, Carlsbad, Calif., U.S.A.), as described in the SUPERSCRIPT II cDNA library synthesis protocol. The cDNA libraries are quality controlled for a good insert:vector ratio.
- The cDNA libraries are plated on LB agar containing the appropriate antibiotics for selection and incubated at 37° for a sufficient time to allow the growth of individual colonies. Single colonies are individually placed in each well of a 96-well microtiter plates containing LB liquid including the selective antibiotics. The plates are incubated overnight at approximately 37° C. with gentle shaking to promote growth of the cultures. The plasmid DNA is isolated from each clone using QIAPREP plasmid isolation kits, using the conditions recommended by the manufacturer (QIAGEN Inc., Valencia, Calif. U.S.A.).
- The template plasmid DNA clones are used for subsequent sequencing. Sequences of recombinant polynucleotides may be obtained by a number of sequencing techniques known in the art, including fluorescence-based sequencing methodologies. These methods have the detection, automation, and instrumentation capability necessary for the analysis of large volumes of sequence data. With these types of automated systems, fluorescent dye-labeled sequence reaction products are detected and data entered directly into the computer, producing a chromatogram that is subsequently viewed, stored, and analyzed using the corresponding software programs. These methods are known to those of skill in the art and have been described and reviewed.
- The open reading frame in each recombinant polynucleotide sequence is identified by a combination of predictive and homology based methods. The longest open reading frame (ORF) is determined, and the top BLAST match is identified by BLASTX against NCBI. The top BLAST hit is then compared to the predicted ORF, with the BLAST hit given precedence in the case of discrepancies.
- Functions of polypeptides encoded by the polynucleotide sequences of the present invention are determined using a hierarchical classification tool, termed FunCAT, for Functional Categories Annotation Tool. Most categories collected in FunCAT are classified by function, although other criteria are used, for example, cellular localization or temporal process. The assignment of a functional category to a query sequence is based on BLASTX sequence search results, which compare two protein sequences. FunCAT assigns categories by iteratively scanning through all blast hits, starting with the most significant match, and reporting the first category assignment for each FunCAT source classification scheme. In the present invention, function of a query polypeptide is inferred from the function of a protein homolog where either (1) hit_p<1e-30 or % identity>35% AND query_coverage>50% AND hit_coverage>50%, or (2) hit_p<1e-8 AND query_coverage>70% AND hit_coverage>70%.
- Functional assignments from five public classification schemes, GO_BP, GO_CC, GO_MF, KEGG, and EC, and one internal Monsanto classification scheme, POI, are provided in Table 1 from U.S. Pub. No. 2007/0044171. The column under the heading “CAT_TYPE” indicates the source of the classification. GO_BP=Gene Ontology Consortium—biological process; GO_CC=Gene Ontology Consortium—cellular component; GO_MF=Gene Ontology Consortium—molecular function; KEGG=KEGG functional hierarchy; EC=Enzyme Classification from ENZYME data bank release 25.0; POI=Pathways of Interest. The column under the heading “CAT_DESC” provides the name of the subcategory into which the query sequence was classified. The column under the heading “PRODUCT_HIT_DESC” provides a description of the BLAST hit to the query sequences that led to the specific classification. The column under the heading “HIT_E” provides the e-value for the BLAST hit. It is noted that the e-value in the HIT_E column may differ from the e-value based on the top BLAST hit provided in the E_VALUE column since these calculations were done on different days, and database size is an element in E-value calculations. E-values obtained by BLASTing against public databases, such as GenBank, will generally increase over time for any given query/entry match.
- Sequences useful for producing transgenic plants having improved biological properties are identified from their FunCAT annotations and are also provided in Table 1 from U.S. Pub. No. 2007/0044171. A biological property of particular interest is plant yield. Plant yield may be improved by alteration of a variety of plant pathways, including those involving nitrogen, carbohydrate, or phosphorus utilization and/or uptake. Plant yield may also be improved by alteration of a plant's photosynthetic capacity or by improving a plant's ability to tolerate a variety of environmental stresses, including cold, heat, drought and osmotic stresses. Other biological properties of interest that may be improved using sequences of the present invention include pathogen or pest tolerance, herbicide tolerance, disease resistance, growth rate (for example by modification of cell cycle, by expression of transcription factors, or expression of growth regulators), seed oil and/or protein yield and quality, rate and control of recombination, and lignin content.
- Sequences of recombinant polynucleotides are provided herein as SEQ ID NO: 1 through SEQ ID NO: 105,582 and sequences of recombinant polypeptides are provided as SEQ ID NO: 105,583 through SEQ ID NO: 211,164. Descriptions of each of these recombinant polynucleotide and recombinant polypeptide sequences are provided in Table 1 from U.S. Pub. No. 2007/0044171.
- Table 1 from U.S. Pub. No. 2007/0044171 Column Descriptions
- SEQ_NUM provides the SEQ ID NO for the listed recombinant polynucleotide sequences.
- CONTIG_ID provides an arbitrary sequence name taken from the name of the clone from which the cDNA sequence was obtained.
- PROTEIN_NUM provides the SEQ ID NO for the recombinant polypeptide sequence
- NCBI_GI provides the GENBANK ID number for the top BLAST hit for the sequence. The top BLAST hit is indicated by the National Center for Biotechnology Information GENBANK Identifier number.
- NCBI_GI_DESCRIPTION refers to the description of the GENBANK top BLAST hit for the sequence.
- E_VALUE provides the expectation value for the top BLAST match.
- MATCH_LENGTH provides the length of the sequence which is aligned in the top BLAST match
- TOP_HIT_PCT_IDENT refers to the percentage of identically matched nucleotides (or residues) that exist along the length of that portion of the sequences which is aligned in the top BLAST match.
- CAT_TYPE indicates the classification scheme used to classify the sequence. GO_BP=Gene Ontology Consortium—biological process; GO_CC=Gene Ontology Consortium—cellular component; GO_MF=Gene Ontology Consortium—molecular function; KEGG=KEGG functional hierarchy (KEGG=Kyoto Encyclopedia of Genes and Genomes); EC=Enzyme Classification from ENZYME data bank release 25.0; POI=Pathways of Interest.
- CAT_DESC provides the classification scheme subcategory to which the query sequence was assigned.
- PRODUCT_CAT_DESC provides the FunCAT annotation category to which the query sequence was assigned.
- PRODUCT_HIT_DESC provides the description of the BLAST hit which resulted in assignment of the sequence to the function category provided in the cat_desc column.
- HIT_E provides the E value for the BLAST hit in the hit_desc column.
- PCT_IDENT refers to the percentage of identically matched nucleotides (or residues) that exist along the length of that portion of the sequences which is aligned in the BLAST match provided in hit_desc.
- QRY_RANGE lists the range of the query sequence aligned with the hit.
- HIT_RANGE lists the range of the hit sequence aligned with the query.
- QRY_CVRG provides the percent of query sequence length that matches to the hit (NCBI) sequence in the BLAST match (% qry cvrg=(match length/query total length)×100).
- HIT_CVRG provides the percent of hit sequence length that matches to the query sequence in the match generated using BLAST (% hit cvrg=(match length/hit total length)×100).
- All publications and patent applications cited herein are hereby incorporated by reference in their entirely to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
- Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.
Claims (30)
1) A recombinant polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582.
2) A recombinant polypeptide selected from the group consisting of SEQ ID NO: 105,583 through SEQ ID NO: 211,164.
3) A method of producing a plant having an improved property, wherein said method comprises transforming a plant with a recombinant construct comprising a promoter region functional in a plant cell operably joined to a polynucleotide comprising a coding sequence for a polypeptide associated with said property, and growing said transformed plant, wherein said polypeptide is selected from the group consisting of:
a) a polypeptide useful for improving plant cold tolerance, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
b) a polypeptide useful for manipulating growth rate in plant cells by modification of the cell cycle pathway, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
c) a polypeptide useful for improving plant drought tolerance, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
d) a polypeptide useful for providing increased resistance to plant disease, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
e) a polypeptide useful for galactomannan production, wherein said polynucleotide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
f) a polypeptide useful for production of plant growth regulators, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
g) a polypeptide useful for improving plant heat tolerance, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
h) a polypeptide useful for improving plant tolerance to herbicides, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
i) a polypeptide useful for increasing the rate of homologous recombination in plants,wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
j) a polypeptide useful for lignin production, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
k) a polypeptide useful for improving plant tolerance to extreme osmotic conditions, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
l) a polypeptide useful for improving plant tolerance to pathogens or pests, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
m) a polypeptide useful for yield improvement by modification of photosynthesis, wherein said polynucleotide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
n) a polypeptide useful for modifying seed oil yield and/or content, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
o) a polypeptide useful for modifying seed protein yield and/or content, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
p) a polypeptide encoding a plant transcription factor, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
q) a polypeptide useful for yield improvement by modification of carbohydrate use and/or uptake, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
r) a polypeptide useful for yield improvement by modification of nitrogen use and/or uptake, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171;
s) a polypeptide useful for yield improvement by modification of phosphorus use and/or uptake, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171; and
t) a polypeptide useful for yield improvement by providing improved plant growth and development under at least one stress condition, wherein said polypeptide comprises a sequence identified as such in Table 1 from U.S. Pub. No. 2007/0044171.
4. An exogenous nucleic acid molecule comprising a polynucleotide, wherein said polynucleotide:
(a) hybridizes under high-stringency conditions to a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582, or
(b) exhibits at least about 90% or greater identity to a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582.
5. The exogenous nucleic acid molecule of claim 4 , wherein said nucleic acid molecule encodes a Triticum aestivum protein or fragment thereof.
6. An exogenous nucleic acid molecule comprising a polynucleotide having at least about 90% sequence identity with a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582.
7. The exogenous nucleic acid molecule of claim 6 , wherein said polynucleotide has at least about 95% sequence identity with a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582.
8. The exogenous nucleic acid molecule of claim 7 , wherein said polynucleotide has at least about 98% sequence identity with a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582.
9. The exogenous nucleic acid molecule of claim 8 , wherein said polynucleotide has at least about 99% sequence identity with a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582.
10. A recombinant polypeptide, wherein said polypeptide is encoded by a nucleic acid molecule comprising a polynucleotide, wherein said polynucleotide:
(a) hybridizes under high-stringency conditions to a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582, or
(b) exhibits at least about 90% or greater identity to a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582.
11. A functional variant of the recombinant polypeptide of claim 10 , wherein said functional variant comprises at least about 50 consecutive amino acids having at least about 90% identity to about a 50 amino acid polypeptide fragment of said recombinant polypeptide.
12. A recombinant polypeptide having at least about 90% sequence identity with a recombinant polypeptide selected from the group consisting of SEQ ID NO: 105,583 through SEQ ID NO: 211,164.
13. The recombinant polypeptide of claim 12 , wherein said recombinant polypeptide has at least about 95% sequence identity with a recombinant polypeptide selected from the group consisting of SEQ ID NO: 105,583 through SEQ ID NO: 211,164.
14. A transformed plant comprising a transformed plant cell comprising a recombinant DNA construct which comprises:
(a) a promoter region functional in a plant cell, operably joined to
(b) a recombinant polynucleotide, wherein said recombinant polynucleotide
(i) hybridizes under high-stringency conditions to a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a fragment of either, or
(ii) exhibits at least about 90% or greater identity to a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a fragment of either, which is linked to
(c) a 3′ non-translated sequence that functions in said plant cell to cause the termination of transcription of said recombinant polynucleotide.
15. The transformed plant according to claim 14 , wherein said polynucleotide is a complete complement of a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582 or a fragment thereof.
16. The transformed plant according to claim 14 , wherein said plant is selected from the group consisting of soy, maize, cotton and wheat.
17. A transformed plant comprising a recombinant DNA construct comprising a recombinant polynucleotide that encodes a polypeptide, wherein said polypeptide has at least about 90% sequence identity with an polypeptide selected from the group consisting of SEQ ID NO: 105,583 through SEQ ID NO: 211,164, or a fragment thereof.
18. A transformed seed comprising a transformed plant cell comprising a recombinant DNA construct which comprises:
(a) a promoter region functional in a plant cell, operably joined to
(b) a recombinant polynucleotide, wherein said recombinant polynucleotide
(i) hybridizes under high-stringency conditions to a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582, or
(ii) exhibits at least about 90% or greater identity to a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582, which is linked to
(c) a 3′ non-translated sequence that functions in said plant cell to cause the termination of transcription of said recombinant polynucleotide.
19. The transformed seed according to claim 18 , wherein said polynucleotide is a complete complement of a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582.
20. The transformed seed according to claim 19 , wherein said seed is selected from the group consisting of soy, maize, cotton and wheat seed.
21. A transformed seed comprising a transformed plant cell comprising an exogenous nucleic acid molecule comprising a recombinant polynucleotide that encodes a polypeptide, wherein said polypeptide has at least about 90% sequence identity with an polypeptide selected from the group consisting of SEQ ID NO: 105,583 through SEQ ID NO: 211,164.
22. A method of producing a genetically transformed plant, comprising the steps of:
(a) inserting into the genome of a plant cell a recombinant polynucleotide comprising:
(i) a promoter region functional in said plant cell, operably joined to
(ii) a polynucleotide that
(A) hybridizes under high-stringency conditions to a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582, or
(B) exhibits at least about 90% or greater identity to a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582, which is linked to
(iii) a 3′ non-translated sequence that functions in said plant cell to cause the termination of transcription of said polynucleotide,
(b) obtaining a transformed plant cell with said recombinant polynucleotide, wherein said recombinant polynucleotide is transcribed and results in expression of one or more proteins; and
(c) regenerating from said transformed plant cell a genetically transformed plant.
23. A method for decreasing expression of a protein in a plant cell comprising growing a transformed plant cell containing a polynucleotide wherein the non-transcribed strand of said polynucleotide encodes a protein or fragment thereof, and wherein the transcribed strand of said polynucleotide is complementary to a polynucleotide selected from the group consisting of SEQ ID NO:1 through SEQ ID NO: 105,582, a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a fragment of either, and whereby said transcribed strand decreases or supresses expression of said protein.
24. A method for increasing expression of a protein in a plant cell comprising growing a transformed plant cell containing a polynucleotide that encodes a protein or fragment thereof, wherein said polynucleotide is selected from the group consisting of SEQ ID NO:1 through SEQ ID NO: 105,582, a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582 and a fragment of either, and whereby said polynucleotide increases expression of said protein.
25. A method of producing a plant containing reduced levels of a protein comprising:
(a) transforming a plant cell with a polynucleotide selected from the group consisting of SEQ ID NO:1 through SEQ ID NO: 105,582, a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a fragment of either, wherein said polynucleotide is transcribed and results in decreased expression or cosuppression of endogenous protein synthesis activity, and
(b) regenerating said plant comprising said plant cell and producing subsequent progeny from said plant.
26. A method of growing a transgenic plant comprising
(a) planting a transformed seed comprising a polynucleotide selected from the group consisting of SEQ ID NO:1 through SEQ ID NO: 105,582, and a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582, and
(b) growing a plant from said seed.
27. A method of producing a genetically transformed plant, comprising the steps of
(a) inserting into the genome of a plant cell a recombinant polynucleotide comprising:
(i) a promoter region functional in said plant cell, operably joined to
(ii) a polynucleotide that
(A) hybridizes under high-stringency conditions to a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582, or
(B) exhibits at least about 90% or greater identity to a polynucleotide selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 105,582, and a complete complement of SEQ ID NO: 1 through SEQ ID NO: 105,582, which is linked to
(iii) a 3′ non-translated sequence that functions in said plant cell to cause the termination of transcription of said polynucleotide,
(b) obtaining a transformed plant cell with said recombinant polynucleotide, wherein said recombinant polynucleotide is transcribed and results in expression of one or more proteins; and
(c) regenerating from said transformed plant cell a genetically transformed plant.
28. A method for increasing expression of a protein in a plant cell comprising growing a transformed plant cell containing a polynucleotide that encodes a protein or fragment thereof, wherein said polynucleotide encodes a polypeptide, wherein said polypeptide has at least about 90% sequence identity with an polypeptide selected from the group consisting of SEQ ID NO: 105,583 through SEQ ID NO: 211,164, or a fragment thereof, and whereby said polynucleotide increases expression of said protein.
29. A method of producing a plant containing reduced levels of a protein comprising:
(a) transforming a plant cell with a recombinant polynucleotide encoding a polypeptide having at least about 90% sequence identity with an polypeptide selected from the group consisting of SEQ ID NO: 105,583 through SEQ ID NO: 211,164, or a fragment thereof, wherein said recombinant polynucleotide is transcribed and results in decreased expression or cosuppression of endogenous protein synthesis activity, and
(b) regenerating said plant comprising said plant cell and producing subsequent progeny from said plant.
30. A method of growing a transgenic plant comprising
(a) planting a transformed seed comprising a polynucleotide encoding a polypeptide having at least about 90% sequence identity with an polypeptide selected from the group consisting of SEQ ID NO: 105,583 through SEQ ID NO: 211,164, or a fragment thereof, and
(b) growing a plant from said seed.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/785,162 US20110209246A1 (en) | 2000-12-14 | 2007-04-16 | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
US13/507,812 US20130185831A1 (en) | 2000-12-14 | 2012-07-31 | Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
US14/182,694 US20140259218A1 (en) | 2000-12-14 | 2014-02-18 | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
US15/047,375 US20160319294A1 (en) | 2000-12-14 | 2016-02-18 | Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25557500P | 2000-12-14 | 2000-12-14 | |
US2033801A | 2001-12-12 | 2001-12-12 | |
US10/703,032 US7214786B2 (en) | 2000-12-14 | 2003-11-06 | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
US11/785,162 US20110209246A1 (en) | 2000-12-14 | 2007-04-16 | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/703,032 Division US7214786B2 (en) | 2000-12-14 | 2003-11-06 | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/507,812 Continuation US20130185831A1 (en) | 2000-12-14 | 2012-07-31 | Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110209246A1 true US20110209246A1 (en) | 2011-08-25 |
Family
ID=46324965
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/703,032 Expired - Lifetime US7214786B2 (en) | 2000-12-14 | 2003-11-06 | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
US11/785,162 Abandoned US20110209246A1 (en) | 2000-12-14 | 2007-04-16 | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
US13/507,812 Abandoned US20130185831A1 (en) | 2000-12-14 | 2012-07-31 | Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
US14/182,694 Abandoned US20140259218A1 (en) | 2000-12-14 | 2014-02-18 | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
US15/047,375 Abandoned US20160319294A1 (en) | 2000-12-14 | 2016-02-18 | Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/703,032 Expired - Lifetime US7214786B2 (en) | 2000-12-14 | 2003-11-06 | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/507,812 Abandoned US20130185831A1 (en) | 2000-12-14 | 2012-07-31 | Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
US14/182,694 Abandoned US20140259218A1 (en) | 2000-12-14 | 2014-02-18 | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
US15/047,375 Abandoned US20160319294A1 (en) | 2000-12-14 | 2016-02-18 | Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
Country Status (1)
Country | Link |
---|---|
US (5) | US7214786B2 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080141390A1 (en) * | 2006-12-08 | 2008-06-12 | Iowa State University Research Foundation, Inc. | Plant genes involved in nitrate uptake and metabolism |
US9029321B2 (en) | 2011-03-30 | 2015-05-12 | Board Of Regents Of The University Of Texas | Methods and compositions for targeting adipose cells in mammals |
WO2017044895A3 (en) * | 2015-09-10 | 2017-06-08 | City Of Hope | MVA-gH/gL-PC VACCINE DERIVED ANTIBODIES NEUTRALIZING HUMAN CYTOMEGALOVIRUS INFECTIVITY AND METHODS THEREOF |
CN107853054A (en) * | 2017-11-22 | 2018-03-30 | 中国热带农业科学院椰子研究所 | Coconut Evaluation of Cold Tolerance method based on mathematical model |
WO2018129090A1 (en) * | 2017-01-03 | 2018-07-12 | Trellis Bioscience, Llc | Native human antibodies for immune checkpoint modulation targets tim-3 and b7-h3 |
CN108492202A (en) * | 2018-02-12 | 2018-09-04 | 中国农业科学院郑州果树研究所 | A kind of identification method of resistance to overhead flooding injury Germplasm Resources in Genera Actinidia |
AU2013310979B2 (en) * | 2012-08-27 | 2018-12-13 | Evogene Ltd. | Isolated polynucleotides, polypeptides and methods of using same for increasing abiotic stress tolerance, biomass and yield of plants |
US10376575B2 (en) | 2012-07-27 | 2019-08-13 | City Of Hope | MVA vaccine for delivery of a UL128 complex and preventing CMV infection |
CN110922457A (en) * | 2019-11-14 | 2020-03-27 | 南京农业大学 | Plant immune induced resistance protein FgPII1 secreted by fusarium graminearum and application thereof |
US10745447B2 (en) | 2015-09-28 | 2020-08-18 | The University Of North Carolina At Chapel Hill | Methods and compositions for antibody-evading virus vectors |
US11905523B2 (en) | 2019-10-17 | 2024-02-20 | Ginkgo Bioworks, Inc. | Adeno-associated viral vectors for treatment of Niemann-Pick Disease type-C |
US11976096B2 (en) | 2018-04-03 | 2024-05-07 | Ginkgo Bioworks, Inc. | Antibody-evading virus vectors |
US11981914B2 (en) | 2019-03-21 | 2024-05-14 | Ginkgo Bioworks, Inc. | Recombinant adeno-associated virus vectors |
US12060390B2 (en) | 2018-04-03 | 2024-08-13 | Ginkgo Bioworks, Inc. | Antibody-evading virus vectors |
Families Citing this family (302)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8030546B2 (en) * | 1998-09-22 | 2011-10-04 | Mendel Biotechnology, Inc. | Biotic and abiotic stress tolerance in plants |
US7888558B2 (en) * | 1999-11-17 | 2011-02-15 | Mendel Biotechnology, Inc. | Conferring biotic and abiotic stress tolerance in plants |
US7345217B2 (en) * | 1998-09-22 | 2008-03-18 | Mendel Biotechnology, Inc. | Polynucleotides and polypeptides in plants |
US7612251B2 (en) * | 2000-09-26 | 2009-11-03 | Pioneer Hi-Bred International, Inc. | Nucleotide sequences mediating male fertility and method of using same |
US7442761B2 (en) * | 2003-06-06 | 2008-10-28 | Samuel Bogoch | Replikin peptides and uses thereof |
EP1377604B1 (en) * | 2001-04-12 | 2014-12-31 | Academisch Ziekenhuis Leiden | Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides |
US8491896B2 (en) * | 2002-06-14 | 2013-07-23 | Immunomedics, Inc. | Anti-pancreatic cancer antibodies |
WO2003100045A1 (en) * | 2002-05-23 | 2003-12-04 | Wolfgang Knecht | Plant thymidine kinases and their use |
JP4489582B2 (en) * | 2002-05-28 | 2010-06-23 | オムリクス・バイオフアーマシユーチカルズ・インコーポレーテツド | Methods for obtaining anti-idiotype antibodies |
US9599619B2 (en) | 2002-06-14 | 2017-03-21 | Immunomedics, Inc. | Anti-pancreatic cancer antibodies |
US8821868B2 (en) | 2002-06-14 | 2014-09-02 | Immunomedics, Inc. | Anti-pancreatic cancer antibodies |
AU2003258127A1 (en) * | 2002-08-06 | 2004-02-23 | Diadexus, Inc. | Compositions and methods relating to ovarian specific genes and proteins |
CA2421086A1 (en) * | 2003-02-28 | 2004-08-28 | Institut Pasteur | Chicken rna polymerase i promoter and its use |
EP1622933A2 (en) * | 2003-04-22 | 2006-02-08 | Intercell AG | H. pylori antigens |
US7148032B2 (en) * | 2003-04-28 | 2006-12-12 | Novozymes A/S | Phospholipase |
AU2003902413A0 (en) * | 2003-05-16 | 2003-06-05 | Agresearch Limited | Modification of fatty acid biosynthesis |
US7554007B2 (en) * | 2003-05-22 | 2009-06-30 | Evogene Ltd. | Methods of increasing abiotic stress tolerance and/or biomass in plants |
AU2005234725B2 (en) * | 2003-05-22 | 2012-02-23 | Evogene Ltd. | Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby |
US9005613B2 (en) | 2003-06-16 | 2015-04-14 | Immunomedics, Inc. | Anti-mucin antibodies for early detection and treatment of pancreatic cancer |
PT1638443E (en) * | 2003-06-20 | 2011-01-25 | Mayo Foundation | Isoforms of brain natriuretic peptide |
WO2005010031A1 (en) * | 2003-07-30 | 2005-02-03 | Japan Science And Technology Agency | Peptides capable of binding to titanium, silver and silicone |
AU2004263458B2 (en) * | 2003-08-08 | 2010-06-24 | Actgen, Inc. | Polypeptides having brain-localizing activity and uses thereof |
US7884261B2 (en) | 2004-06-30 | 2011-02-08 | CERES,Inc. | Nucleotide sequences and corresponding polypeptides conferring modulated plant growth rate and biomass in plants |
US7803983B2 (en) * | 2004-06-30 | 2010-09-28 | Ceres, Inc. | Nucleotide sequences and corresponding polypeptides conferring modulated plant growth rate and biomass in plants |
US20100310753A1 (en) * | 2004-06-30 | 2010-12-09 | Nickolai Alexandrov | Nucleotide sequences and corresponding polypeptides conferring modulated plant growth rate and biomass in plants |
US7220405B2 (en) * | 2003-09-08 | 2007-05-22 | E. I. Du Pont De Nemours And Company | Peptide-based conditioners and colorants for hair, skin, and nails |
WO2005046709A2 (en) * | 2003-11-06 | 2005-05-26 | Genencor International, Inc. | Tgf - beta binding and supported peptides |
US7674884B2 (en) * | 2003-12-10 | 2010-03-09 | Novimmune S.A. | Neutralizing antibodies and methods of use thereof |
DE10359351A1 (en) * | 2003-12-16 | 2005-07-21 | Merck Patent Gmbh | DNA sequence and recombinant production of group-4 major allergens from cereals |
US20070185021A1 (en) * | 2004-01-09 | 2007-08-09 | Scott Fraser W | Diabetogenic epitopes |
EP1724280A1 (en) * | 2004-03-08 | 2006-11-22 | Universidad De Barcelona | Use of peptides as penetrating cell carriers |
EP2336330B1 (en) * | 2004-06-14 | 2018-01-10 | Evogene Ltd. | Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
US8563682B2 (en) * | 2004-06-25 | 2013-10-22 | Thomas Jefferson University | Guanylylcyclase C ligands |
US20070269523A1 (en) * | 2004-08-06 | 2007-11-22 | Tissue Targeting Japan Inc. | Carriers Comprising Colloidal Metal Praticles for Translocation into Cerberal Neurons |
US7378278B2 (en) * | 2004-10-15 | 2008-05-27 | Plant Bioscience Limited | Enzymes involved in triterpene synthesis |
US20080244765A1 (en) * | 2004-12-16 | 2008-10-02 | Pioneer Hi-Bred International, Inc. | Methods and compositions for pollination disruption |
JP5089172B2 (en) | 2004-12-17 | 2012-12-05 | 積水メディカル株式会社 | Cancer tissue detection method and cancer tissue detection reagent used in the method |
EP1836307A2 (en) * | 2004-12-20 | 2007-09-26 | Mendel Biotechnology, Inc. | Plant stress tolerance from modified ap2 transcription factors |
EP2163638A1 (en) * | 2004-12-20 | 2010-03-17 | BASF Plant Science GmbH | Nucleic acid molecules encoding fatty acid desaturase genes from plants and methods of use |
RU2421462C2 (en) | 2005-07-29 | 2011-06-20 | Таргитид Гроус, Инк. | Protective action of dominant-negative mutant protein krp from inhibiting wild-type active complex cyclin-cdk krp |
US20090092583A1 (en) * | 2005-08-26 | 2009-04-09 | Makoto Sawada | Brain-localizing cells and uses thereof |
NZ550699A (en) * | 2005-10-21 | 2008-03-28 | Fonterra Co Operative Group | Compositions and methods for producing plants with stress tolerance |
MX350551B (en) * | 2005-10-24 | 2017-09-08 | Evogene Ltd | Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same. |
CA2634934A1 (en) * | 2005-12-23 | 2007-07-05 | The Burnham Institute For Medical Research | Endometriosis cell targeting peptide and uses thereof |
MX2008015093A (en) * | 2006-05-30 | 2009-02-25 | Cropdesign Nv | Plants with modulated expression of extensin receptor-like kinase having enhanced yield-related traits and a method for making the same. |
AU2007266252B2 (en) * | 2006-05-31 | 2013-07-04 | Adelaide Research And Innovation Pty Ltd | Transcription regulators for reproduction associated plant part tissue specific expression |
US7977535B2 (en) | 2006-07-12 | 2011-07-12 | Board Of Trustees Of Michigan State University | DNA encoding ring zinc-finger protein and the use of the DNA in vectors and bacteria and in plants |
BRPI0716416A2 (en) | 2006-08-08 | 2016-10-11 | Mayo Foundation | substantially pure polypeptide between 37 and 47 amino acid in length, isolated nucleic acid, vector: host cell and pharmaceutical composition |
US8604272B2 (en) * | 2006-09-28 | 2013-12-10 | Monsanto Technology Llc | Resistance to gray leaf spot in maize |
WO2008136869A2 (en) | 2006-12-06 | 2008-11-13 | Burnham Institute For Medical Research | Methods and compositions related to targeting wounds, regenerating tissue, and tumors |
MX349479B (en) | 2006-12-20 | 2017-07-31 | Evogene Ltd | Polynucleotides and polypeptides involved in plant fiber development and methods of using same. |
CN101687907B (en) * | 2007-03-08 | 2016-03-30 | 新西兰植物和食品研究院有限公司 | Transferring enzyme, epimerase, their polynucleotide and uses thereof of encoding |
WO2008122980A2 (en) * | 2007-04-09 | 2008-10-16 | Evogene Ltd. | Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants |
US20080301836A1 (en) * | 2007-05-17 | 2008-12-04 | Mendel Biotechnology, Inc. | Selection of transcription factor variants |
US20100183750A1 (en) * | 2007-06-22 | 2010-07-22 | Universiteit Gent | Fortification of plants with folates by metabolic engineering |
US7994393B2 (en) * | 2007-06-29 | 2011-08-09 | The Chinese University Of Hong Kong | Method to improve plant resistance to infections |
KR100845146B1 (en) * | 2007-07-05 | 2008-07-09 | 경상대학교산학협력단 | Antifungal agent containing rice peroxisomal receptor protein as active ingredient |
WO2009009836A1 (en) * | 2007-07-17 | 2009-01-22 | Grain Foods Crc Ltd | Genetic basis for improved milling performance |
AU2008278654B2 (en) | 2007-07-24 | 2014-06-05 | Evogene Ltd. | Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same |
MY156447A (en) * | 2007-07-26 | 2016-02-26 | Puthigae Sathish | Methods and polynucleotides for improving plants |
RU2483078C2 (en) * | 2007-08-20 | 2013-05-27 | Онкотерапи Сайенс, Инк. | Cdh3-peptide and drug preparation containing it |
PT2186889E (en) * | 2007-08-20 | 2015-06-17 | Oncotherapy Science Inc | Cdca1 peptide and pharmaceutical agent comprising the same |
JP5087349B2 (en) * | 2007-09-07 | 2012-12-05 | ホクレン農業協同組合連合会 | Genes for low-temperature germination of rice and their utilization |
US8648229B2 (en) * | 2007-09-12 | 2014-02-11 | Australian Centre For Plant Functional Genomics Pty Ltd | Plant seed active transcriptional control sequences |
US20090176272A1 (en) * | 2007-09-12 | 2009-07-09 | Kuehnle Agrosystems, Inc. | Expression of nucleic acid sequences for production of biofuels and other products in algae and cyanobacteria |
WO2009036448A2 (en) * | 2007-09-15 | 2009-03-19 | Mayo Foundation For Medical Education And Research | Natriuretic peptide receptor-c agonists |
WO2009054735A2 (en) * | 2007-10-26 | 2009-04-30 | Vialactia Biosciences (Nz) Limited | Polynucleotides and methods for the improvement of plants |
BRPI0817134A2 (en) * | 2007-10-31 | 2017-05-02 | Du Pont | plant, method of alteration and evaluation of plant root architecture, method of determining alteration of an agronomic trait in a plant, isolated polynucleotide, vector, recombinant DNA construction, cell transformation method, cell, plant production method , genetic variation mapping method and molecular cultivation method |
EP2225266B1 (en) * | 2007-11-30 | 2017-04-19 | Phadia AB | Novel wheat allergens |
AU2008343595A1 (en) * | 2007-12-19 | 2009-07-09 | Centocor Ortho Biotech Inc. | A human non-antibody peptide or protein phage library |
NZ564691A (en) * | 2007-12-21 | 2010-03-26 | Nz Inst Plant & Food Res Ltd | Glycosyltransferases, polynucleotides encoding these and methods of use |
AU2008344935C1 (en) * | 2007-12-27 | 2016-07-14 | Evogene Ltd. | Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants |
CN103849647A (en) * | 2008-01-25 | 2014-06-11 | 巴斯夫植物科学有限公司 | Plants having enhanced yield-related traits and a method for making the same |
WO2009094704A1 (en) * | 2008-01-31 | 2009-08-06 | The University Of Adelaide | Seed specific expression in plants |
WO2009105549A2 (en) * | 2008-02-19 | 2009-08-27 | Oncomethylome Sciences Sa | Detection and prognosis of lung cancer |
US20090246754A1 (en) * | 2008-02-19 | 2009-10-01 | Intelligent Mdx | Optimized probes and primers and methods of using same for the detection and quantitation of bk virus |
DE102008014041A1 (en) * | 2008-03-13 | 2009-09-17 | Leibniz-Institut für Pflanzengenetik Und Kulturpflanzenforschung (IPK) | Method of producing broad-spectrum resistance to fungi in transgenic plants |
BRPI0909001A2 (en) * | 2008-03-24 | 2015-07-28 | UNIVERSITé LAVAL | Compositions and methods related to silicon transport |
WO2009123479A1 (en) * | 2008-04-03 | 2009-10-08 | Sathish Puthigae | Gene expression control in plants |
US8802923B2 (en) * | 2008-04-10 | 2014-08-12 | A.B. Seeds Ltd. | Compositions and methods for enhancing oil content in plants |
US20110191896A1 (en) * | 2008-04-14 | 2011-08-04 | Monsanto Technology Llc | Methods and compositions for increasing plant disease resistance and yield |
EP2283125A1 (en) * | 2008-04-23 | 2011-02-16 | E. I. du Pont de Nemours and Company | Drought tolerant plants and related constructs and methods involving genes encoding protein tyrosine phosphatases |
WO2009141824A2 (en) * | 2008-05-22 | 2009-11-26 | Evogene Ltd. | Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficieny |
US9051578B2 (en) * | 2008-05-28 | 2015-06-09 | Insight Genomics Limited | Methods and compositions for plant improvement |
CN102099476A (en) * | 2008-06-03 | 2011-06-15 | 维亚拉克什亚生物科学(新西兰)有限公司 | Compositions and methods for improving plants |
CN101597610B (en) * | 2008-06-05 | 2012-11-21 | 中国科学院遗传与发育生物学研究所 | Vertical compact panicle gene and application thereof |
TWI526219B (en) * | 2008-06-19 | 2016-03-21 | 腫瘤療法 科學股份有限公司 | Cdca1 epitope peptides and vaccines containing the same |
CN102131813B (en) * | 2008-06-24 | 2014-07-30 | 科德克希思公司 | Biocatalytic processes for preparation of substantially stereomerically pure fused bicyclic proline compounds |
CN102143971A (en) | 2008-07-04 | 2011-08-03 | 巴斯夫植物科学有限公司 | Plants having enhanced yield-related traits and a method for making the same by overexpressing a polynucleotide encoding a TFL1-like protein |
WO2010014830A2 (en) * | 2008-07-30 | 2010-02-04 | Cosmix Therapeutics Llc | Peptide therapeutics that bind vegf and methods of use thereof |
UA112050C2 (en) * | 2008-08-04 | 2016-07-25 | БАЄР ХЕЛСКЕР ЛЛСі | THERAPEUTIC COMPOSITION CONTAINING MONOCLONAL ANTIBODY AGAINST TISSUE FACTOR INHIBITOR (TFPI) |
JP5919604B2 (en) * | 2008-08-08 | 2016-05-18 | イミューノメディクス、インコーポレイテッドImmunomedics, Inc. | Anti-pancreatic cancer antibody |
WO2011091113A2 (en) | 2010-01-22 | 2011-07-28 | Immunomedics, Inc. | Detection of early-stage pancreatic adenocarcinoma |
AU2009283785B2 (en) * | 2008-08-18 | 2016-01-28 | Evogene Ltd. | Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants |
TW201008574A (en) | 2008-08-19 | 2010-03-01 | Oncotherapy Science Inc | INHBB epitope peptides and vaccines containing the same |
US20110030104A1 (en) | 2008-08-29 | 2011-02-03 | Los Alamos National Security, Llc | Nucleic acids encoding plant glutamine phenylpyruvate transaminase (GPT) and uses thereof |
US20110030089A1 (en) | 2008-08-29 | 2011-02-03 | Los Alamos National Security, Llc | Transgenic plants with enhanced growth characteristics |
DE112009002267T5 (en) * | 2008-09-23 | 2012-01-19 | Basf Plant Science Gmbh | Plants with increased yield (LT) |
BRPI0918991A2 (en) * | 2008-09-24 | 2017-09-19 | Basf Plant Science Gmbh | METHODS TO ENHANCE YIELD-RELATED TRAITS IN PLANT RELATION TO CONTROL PLANTS, AND TO PRODUCE A TRANSGENIC PLANT, PLANT, PLANT PART OR PLANT CELL, CONSTRUCTION, USE OF A CONSTRUCTION, HARVESTABLE PARTS OF A PLANT, PRODUCTS, USE INTO A NUCLEIC ACID, ISOLATED NUCLEIC ACID MOLECULE AND, ISOLATED POLYPEPTIDE |
US8999919B2 (en) | 2008-10-22 | 2015-04-07 | Trustees Of Dartmouth College | Compositions and methods for inhibiting the interaction between CFTR and CAL |
US9421239B2 (en) | 2008-10-22 | 2016-08-23 | Trustees Of Dartmouth College | Therapy and kit for the prevention and treatment of cystic fibrosis |
US9333235B2 (en) | 2008-10-22 | 2016-05-10 | Trustees Of Dartmouth College | Combination therapy and kit for the prevention and treatment of cystic fibrosis |
WO2010048125A2 (en) * | 2008-10-22 | 2010-04-29 | Trustees Of Dartmouth College | Compositions and methods for inhibiting the interaction between cftr and cal |
US8921658B2 (en) | 2008-10-30 | 2014-12-30 | Evogene Ltd. | Isolated polynucleotides encoding a MAP65 polypeptide and methods of using same for increasing plant yield |
BRPI0921061A2 (en) * | 2008-11-12 | 2016-07-19 | Basf Plant Science Gmbh | methods for enhancing abiotic stress tolerance and / or enhancing plant yield characteristics with respect to a control plant, and for producing a transgenic plant with abiotic stress tolerance and / or yield characteristics for a control plant, parts harvestable, products, construct, plant, plant part, or plant cell, uses of a construct, and a nucleic acid, isolated nucleic acid molecule, and isolated polypeptide |
DK2370456T3 (en) * | 2008-11-26 | 2013-07-01 | Bayer Cropscience Nv | Expression cartridges for seed-specific expression in plants |
WO2010064934A1 (en) * | 2008-12-01 | 2010-06-10 | Vialactia Biosciences (Nz) Limited | Methods and compositions for the improvement of plant tolerance to environmental stresses |
AU2009324213A1 (en) * | 2008-12-03 | 2011-07-07 | Basf Plant Science Gmbh | Plants having enhanced abiotic stress tolerance and/or enhanced yield-related traits and a method for making the same |
AR074925A1 (en) * | 2008-12-29 | 2011-02-23 | Evogene Ltd | POLINUCLEOTIDES, CODED POLYPEPTIDES, AND METHODS TO USE THEM TO MODULATE TOLERANCE TO ABIOTIC STRESS, BIOMASS AND / OR PERFORMANCE IN PLANTS THAT EXPRESS THEM |
EP2208790A1 (en) * | 2009-01-07 | 2010-07-21 | Institut National De La Recherche Agronomique (I.N.R.A.) | Plants producing 2N gametes or apomeiotic gametes |
CN101787074B (en) * | 2009-01-22 | 2012-09-05 | 哈尔滨师范大学 | Leymus chinensis aquaporin and encoding gene and application thereof |
BRPI1008606A2 (en) * | 2009-02-13 | 2017-05-30 | Univ California | plant, plant cell, seed, flower, leaf or fruit, method for increasing stress tolerance in a plant, cassette and expression vector, method for preparing a plant, agricultural chemical formulation, and methods for increasing stress tolerance in a plant and to identify an agent that agonizes a pyr / pyl polypeptide. |
MX342016B (en) | 2009-03-02 | 2016-09-09 | Evogene Ltd | Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics. |
NZ595443A (en) | 2009-04-01 | 2012-08-31 | Vialactia Biosciences Nz Ltd | Control of gene expression in plants using a perennial ryegrass (lolium perenne l.) derived promoter |
MX2011011945A (en) * | 2009-05-13 | 2011-12-06 | Basf Plant Science Co Gmbh | Plant promoter operable in basal endosperm transfer layer of endosperm and uses thereof. |
EP3238534B1 (en) | 2009-06-10 | 2019-11-13 | Evogene Ltd. | Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance |
IL199618A0 (en) | 2009-06-29 | 2010-04-29 | Two To Biotech Ltd | Novel antibodies and their use in diagnostic methods |
WO2011006069A1 (en) * | 2009-07-09 | 2011-01-13 | Georgia Tech Research Corporation | Peptides for binding fibrinogen and fibrin |
BR122019015757B1 (en) | 2009-08-04 | 2021-05-25 | Evogene Ltd | method for increasing abiotic stress tolerance, yield, biomass, growth rate, vigor, and/or nitrogen use efficiency of a plant |
CA2775244A1 (en) * | 2009-09-30 | 2011-04-07 | Novozymes A/S | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
ATE545706T1 (en) * | 2009-10-05 | 2012-03-15 | Univ Ljubljani | CYTOCHROME P450 FROM RHIZOPUS ORYZAE AND USES THEREOF |
CN102051351B (en) * | 2009-10-30 | 2012-07-25 | 中国科学院植物研究所 | Drought-resistance related key enzyme derived from Leymus chinensis (Trin.) Tzvel. as well as coding gene and application thereof |
AU2010319531A1 (en) * | 2009-11-10 | 2012-05-24 | Amgen Inc. | Anti-c-MPL antibodies |
AU2010337936B2 (en) | 2009-12-28 | 2016-06-23 | Evogene Ltd. | Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency |
CN105061571A (en) * | 2010-01-14 | 2015-11-18 | 默克专利股份公司 | Variants of the group-5 allergens of the poaceae with reduced allergenicity by mutagenesis of proline residues |
NZ602115A (en) | 2010-03-01 | 2014-12-24 | Bayer Healthcare Llc | Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi) |
CN101812124B (en) * | 2010-03-10 | 2011-12-21 | 中国农业科学院作物科学研究所 | Plant stress-resistance-associated protein TaSnRK2.8, coding genes and application thereof |
BR112012023503A2 (en) * | 2010-03-19 | 2015-09-01 | Basf Plant Science Co Gmbh | Method for increasing plant yield over control plants, plant, building, use of a building, methods for producing a transgenic plant and a product, harvestable parts of a plant, products derived from a plant, and use of a nucleic acid |
WO2011130801A1 (en) * | 2010-04-23 | 2011-10-27 | George Weston Foods Limited | Wheat immunoreactivity |
CN102234320B (en) * | 2010-04-27 | 2013-07-31 | 中国农业科学院作物科学研究所 | Plant stress-tolerant associated protein TaDREB4B and encoding gene and application thereof |
CN102234323B (en) * | 2010-04-27 | 2013-09-04 | 中国农业科学院作物科学研究所 | Plant stress-tolerance-associated protein TaDREB3A and coding gene and application thereof |
CA2797200C (en) * | 2010-04-28 | 2020-03-31 | Evogene Ltd. | Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics |
CN101851284B (en) * | 2010-05-07 | 2012-03-07 | 河北农业大学 | Plant stress resistance-related membrane protein BjCRP1, and gene and application thereof |
WO2011157806A1 (en) * | 2010-06-16 | 2011-12-22 | Academisch Ziekenhuis Leiden H.O.D.N Lumc | Modified alpha-gliadins |
EA201390111A1 (en) * | 2010-07-16 | 2013-06-28 | Басф Плант Сайенс Компани Гмбх | PLANTS WITH IMPROVED PERFORMANCE CHARACTERISTICS AND METHOD FOR PRODUCING THEM |
WO2012021500A2 (en) * | 2010-08-12 | 2012-02-16 | Pioneer Hi-Bred International, Inc. | Antipathogenic proteins and methods of use |
CN101914147B (en) * | 2010-08-20 | 2013-01-16 | 中国农业科学院作物科学研究所 | Plant disease resistance-related protein and coding gene and application thereof |
AR082530A1 (en) | 2010-08-30 | 2012-12-12 | Evogene Ltd | POLINUCLEOTIDES AND ISOLATED POLYPEPTIDES, AND METHODS TO USE THEM TO INCREASE EFFECTIVENESS IN THE USE OF NITROGEN, PERFORMANCE, GROWTH RATE, VIGOR, BIOMASS, OIL CONTENT AND / OR TOLERANCE TO STRESS ABIOTI |
EP2619311A4 (en) * | 2010-09-24 | 2014-03-05 | Basf Plant Science Co Gmbh | Plants having enhanced yield-related traits and method for making the same |
CA2821257C (en) | 2010-12-22 | 2020-12-22 | Evogene Ltd. | Isolated polynucleotides and polypeptides, and methods of using same for increasing abiotic stress tolerance, yield, growth rate, vigor, biomass, oil content, and/or nitrogen use efficiency of plants |
US20140298508A1 (en) * | 2010-12-23 | 2014-10-02 | Philip Morris Products S.A. | Alpha-mannosidases from plants and methods for using the same |
WO2012096881A2 (en) * | 2011-01-12 | 2012-07-19 | Kansas State University Research Foundation | Mayetiola destructor susceptibility gene one (mds-1) and its application in pest management |
EP2673292A4 (en) * | 2011-02-08 | 2014-05-21 | Phadia Ab | Wheat antigens and peptides for diagnosis of wheat induced hypersensitivity |
WO2012112443A2 (en) | 2011-02-15 | 2012-08-23 | Immunomedics, Inc. | Anti-mucin antibodies for early detection and treatment of pancreatic cancer |
EA201391232A1 (en) * | 2011-02-25 | 2014-02-28 | Юниверсити Оф Саскачеван | PROTEINS FOR BIOREGULATION OF PATHOGENIC FOR PLANTS OF FUNGI |
CN102154236B (en) * | 2011-03-24 | 2012-12-26 | 北京市农林科学院 | Wheat prematurity associated protein TaMAPK1 and coding gene and use thereof |
EP3351641A1 (en) | 2011-04-08 | 2018-07-25 | Tufts Medical Center, Inc. | Pepducin design and use |
US9556448B2 (en) | 2011-04-11 | 2017-01-31 | Targeted Growth, Inc. | Identification and the use of KRP mutants in plants |
WO2012142116A2 (en) | 2011-04-11 | 2012-10-18 | Targeted Growth, Inc. | Identification and use of krp mutants in wheat |
EP2702156A1 (en) * | 2011-04-27 | 2014-03-05 | Aarhus Universitet | High expression cereal phytase gene |
BR122020018204B1 (en) | 2011-05-03 | 2021-11-03 | Evogene Ltd | METHOD TO INCREASE YIELD, BIOMASS, GROWTH RATE, ABIOTIC STRESS TOLERANCE AND/OR EFFICIENCY IN NITROGEN USE IN A PLANT |
US8748393B2 (en) | 2011-05-13 | 2014-06-10 | The Board Of Trustees Of The Leland Stanford Junior University | Inhibitors of mitochondrial fission and methods of use thereof |
KR101328112B1 (en) * | 2011-05-27 | 2013-11-08 | 연세대학교 산학협력단 | Gene Implicated in Abiotic Stress Tolerance and Transformed Plants with the Same |
US10704056B2 (en) | 2011-07-01 | 2020-07-07 | The Regents Of The University Of California | Constitutively active ABA receptor mutants |
CN103764668B (en) * | 2011-07-09 | 2016-08-17 | 加利福尼亚大学董事会 | Leukemic stem cells targeting ligand and application process |
BR102012019434B1 (en) | 2011-07-26 | 2021-11-09 | Dow Agrosciences Llc | PEST, INSECT, MOLECULE AND DIAGNOSTIC DNA SEQUENCE CONTROL METHODS FOR THE SOYBEAN EVENT 9582.814.19.1 |
AU2012297562B2 (en) | 2011-08-12 | 2016-05-19 | Commonwealth Scientific And Industrial Research Organisation | Methods of controlling fructan synthesis in plants |
WO2013027223A2 (en) | 2011-08-23 | 2013-02-28 | Evogene Ltd. | Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics |
CN103906761B (en) | 2011-08-30 | 2016-12-21 | 梅约医学教育与研究基金会 | Profit sodium polypeptide |
US9056892B2 (en) * | 2011-09-09 | 2015-06-16 | University Of Washington | Retrograde transport peptide and use of same for delivery to central nervous system |
WO2013050318A1 (en) * | 2011-10-07 | 2013-04-11 | Basf Plant Science Company Gmbh | Method of producing plants having increased resistance to pathogens |
WO2013053686A1 (en) * | 2011-10-10 | 2013-04-18 | Basf Plant Science Company Gmbh | Method of producing plants having increased resistance to pathogens |
WO2013053711A1 (en) * | 2011-10-10 | 2013-04-18 | Basf Plant Science Company Gmbh | Method of producing plants having increased resistance to pathogens |
WO2013063755A1 (en) * | 2011-11-01 | 2013-05-10 | Lei Haimin | Oligopeptide for treating liver fibrosis and/or hepatitis b and/or improving liver function |
CN102433310B (en) * | 2011-12-02 | 2013-04-03 | 北京市农林科学院 | Relevant protein TaAOC for regulating and controlling cracking of plant anther as well as gene and application thereof |
EP2606905A1 (en) * | 2011-12-23 | 2013-06-26 | Université de Nantes | Peptides targeting Receptor activator of nuclear factor-kappa B (RANK) and their applications |
EP2812015B1 (en) * | 2011-12-23 | 2016-04-13 | Universite de Nantes | Peptides targeting receptor activator of nuclear factor-kappa b (rank) and their applications |
US10072271B2 (en) | 2011-12-23 | 2018-09-11 | Hangzhou Ruifeng Biotechnology Limited Inc. | Methods for improving crop yield |
BR112014016080A2 (en) | 2011-12-28 | 2020-06-30 | Evogene Ltd., | isolated polynucleotides and polypeptides and methods of using them to increase plant production |
CN102505016B (en) * | 2011-12-29 | 2013-01-23 | 南京农业大学 | Transmembrane protein gene triticum asetivum leucine rich repeat 3 (TaLRR3) with leucine rich repeat (LRR) structure domain as well as expression vector and application thereof |
US9611305B2 (en) | 2012-01-06 | 2017-04-04 | Mayo Foundation For Medical Education And Research | Treating cardiovascular or renal diseases |
CN104203277A (en) * | 2012-02-07 | 2014-12-10 | 拉霍拉敏感及免疫学研究所 | Timothy grass allergens and methods and uses for immune response modulation |
CN103290024B (en) * | 2012-03-02 | 2016-01-27 | 中国科学院上海生命科学研究院 | A kind of plant seed absciss layer district developmental regulation gene and application thereof |
JP6202832B2 (en) * | 2012-03-08 | 2017-09-27 | 国立研究開発法人農業・食品産業技術総合研究機構 | Environmental stress-tolerant plant having high seed yield and its production method |
CN104364259A (en) | 2012-03-26 | 2015-02-18 | 普罗努塔利亚公司 | Nutritive fragments, proteins and methods |
AU2013240271A1 (en) | 2012-03-26 | 2014-10-02 | Axcella Health Inc. | Nutritive fragments, proteins and methods |
US20150126441A1 (en) * | 2012-03-26 | 2015-05-07 | Pronutria, Inc. | Nutritive Fragments and Proteins with Low or No Phenylalanine and Methods |
SG10201604464SA (en) | 2012-03-26 | 2016-07-28 | Axcella Health Inc | Charged nutritive proteins and methods |
WO2013148328A1 (en) | 2012-03-26 | 2013-10-03 | Pronutria, Inc. | Nutritive proteins and methods |
CN103374064B (en) * | 2012-04-24 | 2015-02-11 | 中国农业大学 | Plant root hair development related protein TaRSL4, and coding gene and application thereof |
AU2013266244B2 (en) * | 2012-05-23 | 2019-02-28 | Corteva Agriscience Llc | Brassica genomic assays |
CN103509766B (en) * | 2012-06-15 | 2015-03-04 | 中国农业科学院作物科学研究所 | Plant stress tolerance related protein TaPK, and coding gene and application thereof |
WO2014010229A1 (en) | 2012-07-10 | 2014-01-16 | Oncotherapy Science, Inc. | Cdca1 epitope peptides for th1 cells and vaccines containing the same |
WO2014011859A2 (en) * | 2012-07-13 | 2014-01-16 | Pioneer Hi-Bred International, Inc. | Molecular markers for various traits in wheat and methods of use |
CN102807984B (en) * | 2012-07-17 | 2013-07-17 | 南京农业大学 | Molecular marker for wheat yellow mosaic bymovirus resistant major-effect quantitative trait locus (QTL) of Yining wheat and application thereof |
CN102816760A (en) * | 2012-07-30 | 2012-12-12 | 江苏里下河地区农业科学研究所 | Linked marker of Puccinia graminis f. sp. tritici-resistant gene of Dasypyrum villosum (L.) Candarge 6VL chromosome, primer pair and use of the linked marker and the primer pair |
KR101416506B1 (en) | 2012-08-10 | 2014-07-09 | 연세대학교 산학협력단 | Gene Implicated in Abiotic Stress Tolerance and Growth Accelerating and Use Thereof |
TR201809053T4 (en) * | 2012-08-16 | 2018-07-23 | Bangladesh Jute Res Institute | Pectin degradation enzymes from Macrophomina phaseolina and their uses. |
US9758591B2 (en) | 2012-08-24 | 2017-09-12 | The Regents Of The University Of California | Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis |
CA3172506A1 (en) | 2012-09-06 | 2014-03-13 | Pioneer Hi-Bred International, Inc. | Compositions and methods comprising male fertility sequences |
US9388213B2 (en) * | 2012-09-10 | 2016-07-12 | The Rockefeller University | Polycomb repressive complex 2 (PRC2) inhibitors and uses thereof |
WO2014066497A2 (en) * | 2012-10-23 | 2014-05-01 | Montana State University | Production of high quality durum wheat having increased amylose content |
ES2776179T3 (en) * | 2012-11-06 | 2020-07-29 | Medimmune Llc | Antibodies directed against surface determinants of S. aureus |
US9267114B2 (en) | 2012-11-07 | 2016-02-23 | Southern Research Institute | Flavivirus envelope protein mutations affecting virion disassembly |
CN103073626B (en) * | 2012-12-11 | 2014-06-04 | 贵州省油菜研究所 | Wheat calreticulin fragment TaCRT1-206, and coding sequence and application thereof |
BR112015015415B1 (en) * | 2012-12-25 | 2022-08-16 | Evogene Ltd. | METHODS TO INCREASE NITROGEN USE EFFICIENCY, GROWTH RATE, BIOMASS, SEED YIELD, PHOTOSYNTHETIC CAPACITY AND/OR TOLERANCE TO ABIOTIC STRESS OF A PLANT, TO PRODUCE A CULTURE, TO GROW A CROP, AND, TO SELECT A PLANT |
DK2958424T3 (en) * | 2013-02-22 | 2020-07-20 | Agriculture Victoria Serv Pty | MANIPULATION OF SELF-INCOMPATIBILITY IN PLANTS |
US9803214B2 (en) | 2013-03-12 | 2017-10-31 | Pioneer Hi-Bred International, Inc. | Breeding pair of wheat plants comprising an MS45 promoter inverted repeat that confers male sterility and a construct that restores fertility |
MX2015012152A (en) | 2013-03-14 | 2016-05-18 | Univ California | Modified pyr/pyl receptors activated by orthogonal ligands. |
US9725701B2 (en) | 2013-03-15 | 2017-08-08 | Iowa Corn Promotion Board | Prokarytoic-type isocitrate dehydrogenase and its application for improving nitrogen utilization in transgenic plants |
WO2014151749A1 (en) * | 2013-03-15 | 2014-09-25 | Pioneer Hi-Bred International, Inc. | Maize microrna sequences and targets thereof for agronomic traits |
US10024856B2 (en) * | 2013-03-21 | 2018-07-17 | Baylor College Of Medicine | Identification and characterization of a peptide affinity reagent for the detection of noroviruses in clinical samples |
US9452228B2 (en) | 2013-04-01 | 2016-09-27 | Immunomedics, Inc. | Antibodies reactive with an epitope located in the N-terminal region of MUC5AC comprising cysteine-rich subdomain 2 (Cys2) |
US9796757B2 (en) * | 2013-04-19 | 2017-10-24 | The Board Of Trustees Of The University Of Illinois | Compositions and method for treating thrombosis |
WO2014188428A1 (en) | 2013-05-22 | 2014-11-27 | Evogene Ltd. | Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics |
WO2015188899A1 (en) * | 2014-06-12 | 2015-12-17 | Deutsches Krebsforschungszentrum | Novel ttv mirna sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention |
CN103360464A (en) | 2013-07-17 | 2013-10-23 | 武汉摩尔生物科技有限公司 | Polypeptide, DNA molecule encoding polypeptide, vector, preparation method and application thereof |
KR20160058940A (en) | 2013-09-25 | 2016-05-25 | 프로뉴트리아 바이오사이언시스, 인코퍼레이티드 | Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof |
CN103524607B (en) * | 2013-10-14 | 2015-04-15 | 中国农业大学 | Wheat heat stress associated protein TaGCN5 as well as coding gene and application thereof |
KR20150047244A (en) | 2013-10-24 | 2015-05-04 | 연세대학교 산학협력단 | Genes Related to Salt or Drought Stress Resistances and Transformed Plants with the Same |
US10544412B2 (en) * | 2013-12-02 | 2020-01-28 | Brandeis University | Directed evolution of multivalent glycopeptides that tightly bind to target proteins |
US10106813B2 (en) | 2014-02-10 | 2018-10-23 | Board Of Trustees Of Michigan State University | Drought-tolerance in plants |
CN103819548B (en) * | 2014-02-18 | 2015-09-30 | 中国农业大学 | Heat Resistance of Plant associated protein TaOPR3 and encoding gene thereof and application |
WO2015131053A1 (en) * | 2014-02-28 | 2015-09-03 | Alk-Abelló A/S | Polypeptides derived from phl p and methods and uses thereof for immune response modulation |
ES2915101T3 (en) | 2014-03-27 | 2022-06-20 | Bird Rock Bio Inc | Antibodies that bind to the human cannabinoid receptor 1 (CB1) |
CN104292318B (en) * | 2014-03-27 | 2017-07-14 | 北京市农林科学院 | A kind of plant drought GAP-associated protein GAP TaRBP2 and its encoding gene and application |
EP3131917B1 (en) * | 2014-04-18 | 2020-06-17 | The Board of Trustees of the Leland Stanford Junior University | Humanized and chimeric monoclonal antibodies to cd99 |
JP6121942B2 (en) | 2014-05-15 | 2017-04-26 | トヨタ自動車株式会社 | Genes for increasing the biomass content of plants and methods for using the same |
WO2015184331A2 (en) * | 2014-05-30 | 2015-12-03 | Kansas State University Research Foundation | Gene encoding fhb1 resistance to fusarium head blight disease and uses thereof |
WO2016000237A1 (en) * | 2014-07-03 | 2016-01-07 | Pioneer Overseas Corporation | Plants having enhanced tolerance to insect pests and related constructs and methods involving insect tolerance genes |
EP2975128A1 (en) | 2014-07-15 | 2016-01-20 | University College Dublin | A gene capable of enhancing salicylic acid-induced cell death in a plant cell and contributing to resistance to the fungal virulence factor deoxynivalenol, and a recombinant construct including the gene |
IL234246A0 (en) * | 2014-08-21 | 2014-11-30 | Omrix Biopharmaceuticals Ltd | Stabilized thrombin |
US9771393B2 (en) * | 2015-03-11 | 2017-09-26 | The United States Of America, As Represented By The Secretary Of Agriculture | Bioactive peptides having insecticide activity |
CN104774247B (en) * | 2015-04-20 | 2018-06-05 | 中国药科大学 | With 3 relevant 5 peptides of integrin receptor α v β |
US10441644B2 (en) | 2015-05-05 | 2019-10-15 | The Regents Of The University Of California | H3.3 CTL peptides and uses thereof |
WO2016179326A1 (en) * | 2015-05-05 | 2016-11-10 | The Regents Of The University Of California | H3.3 ctl peptides and uses thereof |
WO2016179522A1 (en) * | 2015-05-06 | 2016-11-10 | Pioneer Hi-Bred International, Inc. | Methods and compositions for the production of unreduced, non-recombined gametes and clonal offspring |
WO2016191263A1 (en) | 2015-05-22 | 2016-12-01 | Trustees Of Dartmouth College | Therapy and kit for the prevention and treatment of cystic fibrosis |
WO2016205397A2 (en) * | 2015-06-15 | 2016-12-22 | Klibanov Alexander L | Target-specific delivery of therapeutic agents |
WO2016202805A2 (en) * | 2015-06-15 | 2016-12-22 | Consejo Superior De Investigaciones Científicas (Csic) | Targeting of prolamin by rnai in bread wheat |
CN107920490A (en) | 2015-06-19 | 2018-04-17 | 阿凯笛亚生物科学公司 | The wheat of lipoxygenase activity with reduction |
CN105037522A (en) * | 2015-08-31 | 2015-11-11 | 中国农业科学院作物科学研究所 | Wheat leaf curl related protein TaMYB18 and related biological material and application thereof |
IL300015A (en) * | 2015-09-30 | 2023-03-01 | Bird Rock Bio Inc | Antibodies that bind human cannabinoid 1 (cb1) receptor |
US11091533B2 (en) | 2015-11-13 | 2021-08-17 | Oasis Pharmaceuticals, LLC | Protease-activated receptor-2 modulators |
US20180356408A1 (en) * | 2015-11-19 | 2018-12-13 | Base Pair Biotechnologies, Inc. | Methods and materials for sensitive detection of target molecules |
ES2899176T3 (en) * | 2015-11-27 | 2022-03-10 | Kws Saat Se & Co Kgaa | Plants tolerant to low temperatures |
CN107033216B (en) * | 2015-12-08 | 2021-08-03 | 财团法人农业科技研究院 | Peptides targeting cancer stem cells and uses thereof |
EP3389361A4 (en) | 2015-12-18 | 2019-09-11 | Dow Agrosciences LLC | Ribosomal protein L40 (RPL40) NUCLEIC ACID MOLECULES THAT CONFER RESISTANCE TO COLEOPTERAN AND HEMIPTERAN PESTS |
CN105566468B (en) * | 2016-01-11 | 2019-02-01 | 中国农业科学院作物科学研究所 | Plant fertility GAP-associated protein GAP and its application |
CN105646683B (en) * | 2016-03-01 | 2019-05-28 | 中国农业科学院作物科学研究所 | The application of complete salt tolerant protein matter and relevant biological material in regulation plant salt endurance |
WO2017173318A1 (en) * | 2016-03-31 | 2017-10-05 | Kansas State University Research Foundation | Genes and markers for increasing resistance to fusarium head blight disease and uses thereof |
KR101831888B1 (en) * | 2016-04-15 | 2018-04-16 | (주)케어젠 | Peptides Having Activities for Anti-inflammation and Uses Thereof |
BR112018076321A2 (en) | 2016-06-17 | 2019-03-26 | Arcadia Biosciences, Inc. | plants with reduced lipase activity 1 |
CN106086034B (en) * | 2016-06-18 | 2019-07-26 | 南京农业大学 | One wheatear type developmental regulation gene wbh1 and its molecular labeling and application |
KR20240113990A (en) | 2016-06-27 | 2024-07-23 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | Cancer treatment combinations |
AR108940A1 (en) * | 2016-07-04 | 2018-10-10 | Kumiai Chemical Industry Co | TRANSGENIC PLANT THAT HAS RESISTANCE TO HERBICIDES |
GB2552657A (en) * | 2016-07-29 | 2018-02-07 | Elsoms Dev Ltd | Wheat |
CN106048056B (en) * | 2016-08-05 | 2019-07-12 | 安徽农业大学 | A kind of significant relevant SNP marker of wheat seed suspend mode duration and its CAPS label and application |
CN106305042A (en) * | 2016-08-11 | 2017-01-11 | 山西省农业科学院作物科学研究所 | Planting method for interplanting winter wheat and silage corns in Jinzhong basin |
CN106305043A (en) * | 2016-08-11 | 2017-01-11 | 山西省农业科学院作物科学研究所 | Planting method for overseeding summer squash on winter wheat in Jinzhong basin |
US10877037B2 (en) | 2016-11-21 | 2020-12-29 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Fungal toxins and methods related to the same |
US10905120B2 (en) | 2016-11-28 | 2021-02-02 | The Regents Of The University Of California | ABA receptor agonists that modulate transpiration |
CN106416733A (en) * | 2016-12-01 | 2017-02-22 | 山西省农业科学院作物科学研究所 | Planting method for promoting millet growth and protein accumulation |
CN106381343B (en) * | 2016-12-05 | 2019-08-09 | 中国农业科学院作物科学研究所 | One kind molecular labeling TaSnRK2.3A relevant to thousand grain weight of wheat and plant height and its application |
US11116817B2 (en) * | 2017-02-17 | 2021-09-14 | The Curators Of The University Of Missouri | Antimicrobial agents and compositions comprising the same |
CN107056906B (en) * | 2017-03-15 | 2019-08-09 | 中国科学院遗传与发育生物学研究所 | Protein TaTFL1-2D and its encoding gene and application |
CN107164388B (en) * | 2017-06-16 | 2019-12-13 | 山东大学 | Wheat salt-tolerant gene TaPEX1 and application thereof |
CA3072884A1 (en) * | 2017-08-11 | 2019-02-14 | University Of Kentucky Research Foundation | Anti-neurodegenerative therapeutic, method of manufacture, and use |
CN107474125B (en) * | 2017-09-01 | 2020-05-22 | 北京市农林科学院 | Related protein for controlling temperature-sensitive male sterility of wheat, coding gene and application |
US11161911B2 (en) | 2017-10-23 | 2021-11-02 | Go Therapeutics, Inc. | Anti-glyco-MUC1 antibodies and their uses |
CN107746895B (en) * | 2017-11-10 | 2021-02-02 | 四川农业大学 | Molecular marker for improving barley harvest index QTL site under low-phosphorus condition and application |
CN108101962B (en) * | 2017-11-10 | 2021-06-04 | 浙江美保龙生物技术有限公司 | Small molecular polypeptide for specifically improving immune effect of porcine reproductive and respiratory syndrome vaccine and application thereof |
WO2019106662A1 (en) * | 2017-11-29 | 2019-06-06 | Evogene Ltd. | Compositions and methods conferring resistance to fungal diseases |
CN107916299B (en) * | 2017-12-27 | 2021-01-15 | 山西省农业科学院小麦研究所 | Ordinary wheat SNP locus marker and application thereof in wheat related trait detection |
CN108651207A (en) * | 2018-04-03 | 2018-10-16 | 安徽省农业科学院烟草研究所 | A kind of tobacco bacterial wilt sick nursery breeding method based on tobacco-rice sequential cropping cultivation pattern |
CN110408625A (en) * | 2018-04-28 | 2019-11-05 | 未名生物农业集团有限公司 | The construct and method of economical character changes under nitrogen restrictive condition plant and abiotic stress tolerance gene-correlation |
CN110551751B (en) * | 2018-05-30 | 2021-02-09 | 中国农业科学院作物科学研究所 | Wheat plant type regulatory gene and application thereof |
CN110669761B (en) * | 2018-06-15 | 2022-11-04 | 北京大北农生物技术有限公司 | Nucleotide sequences and methods for controlling insect infestation |
US20210269552A1 (en) * | 2018-06-29 | 2021-09-02 | Go Therapeutics, Inc. | Anti-glyco-muc1 antibodies and their uses |
EP3830107A2 (en) * | 2018-08-03 | 2021-06-09 | Voyager Therapeutics, Inc. | Aav variants with enhanced tropism |
WO2020081794A1 (en) * | 2018-10-17 | 2020-04-23 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Metastatic brain tumor targeting peptides |
CN109535236B (en) * | 2018-11-16 | 2022-04-01 | 南京农业大学 | Heme binding protein gene TaHBP1, recombinant interference vector and application thereof |
CN109369783B (en) * | 2018-11-30 | 2021-09-10 | 昆明医科大学 | Polypeptide RDP1, and purification method and application thereof |
CN113874082A (en) * | 2019-02-26 | 2021-12-31 | 索伦托药业有限公司 | Antigen binding proteins that bind BCMA |
BR112021017635A2 (en) * | 2019-03-08 | 2021-11-09 | Univ Rutgers | Compositions and methods for treating Huntington's disease |
CN111875684B (en) * | 2019-04-15 | 2021-12-07 | 中国农业科学院作物科学研究所 | Disease-resistant heat-resistant related protein TaRHP1, related biological material thereof and method for cultivating disease-resistant heat-resistant plants |
JP2022530442A (en) * | 2019-04-24 | 2022-06-29 | マジェンタ セラピューティクス インコーポレイテッド | Anthracycline antibody drug conjugate and its use |
CN110240638B (en) * | 2019-06-10 | 2021-11-05 | 山东农业大学 | Antibacterial peptide constructed by bioinformatics method and application thereof |
CN110684092B (en) * | 2019-06-10 | 2021-11-05 | 山东农业大学 | Antibacterial peptide and application thereof |
CN112250743B (en) * | 2019-07-04 | 2022-05-06 | 中国农业大学 | Wheat drought stress related protein TaWRKY-A and coding gene and application thereof |
AU2020310945A1 (en) * | 2019-07-05 | 2022-01-20 | MINISTER FOR PRIMARY INDUSTRIES AND REGIONAL DEVELOPMENT (Acting through the South Australian Research and Development Institute) | Salinity and/or sodicity tolerant plants |
CN114375335A (en) | 2019-07-19 | 2022-04-19 | 成对植物服务股份有限公司 | Optimized protein linkers and methods of use |
CN112430259B (en) * | 2019-08-22 | 2022-03-15 | 中国农业科学院作物科学研究所 | Wheat salt stress related protein TaCSN5, and coding gene and application thereof |
CN110699481B (en) * | 2019-11-20 | 2021-06-04 | 华中农业大学 | Gene closely related to glucosinolate content of rape leaves, molecular marker and application thereof |
WO2021119756A1 (en) * | 2019-12-20 | 2021-06-24 | PYC Therapeutics Limited | Novel cellular delivery methods |
CN113527450B (en) * | 2020-04-21 | 2023-05-02 | 中国农业科学院作物科学研究所 | Wheat oxidative stress related protein and related biological material and application thereof |
US20240018526A1 (en) * | 2020-07-15 | 2024-01-18 | Facible Biodiagnostics Llc | Deoxyribonucleic acid-based biosensor and associated methods |
CN116391034A (en) | 2020-07-21 | 2023-07-04 | 成对植物服务股份有限公司 | Optimized protein linkers and methods of use |
WO2022120423A1 (en) * | 2020-12-08 | 2022-06-16 | James Cook University | Peptides and uses thereof |
CN112521473B (en) * | 2020-12-09 | 2022-03-25 | 北京市农林科学院 | Wheat male sterility related protein TaMYB97, and coding gene and application thereof |
CN112708632B (en) * | 2021-01-30 | 2022-09-13 | 河南农业大学 | Application of non-coding RNA molecule in wheat high-yield molecule breeding |
EP4291218A1 (en) * | 2021-02-11 | 2023-12-20 | Ramot at Tel-Aviv University Ltd. | Compositions and methods for treating a disease |
WO2022232315A1 (en) * | 2021-04-27 | 2022-11-03 | Quaero Pharmaceuticals Llc | Compounds |
EP4347614A1 (en) * | 2021-05-26 | 2024-04-10 | Universidad de Chile | Method for simultaneous detection and quantification of listeria monocytogenes, salmonella spp., and shiga toxin-producing escherichia coli (stec) |
CN113527455B (en) * | 2021-08-30 | 2023-10-13 | 山东大学 | Seed development related protein TaGSR1 and application thereof in wheat strain type breeding |
CN114807184B (en) * | 2021-12-06 | 2023-06-09 | 西藏自治区农牧科学院农业研究所 | Application of highland barley cyanidin 5-oxygen glycosyltransferase |
CN114807183B (en) * | 2021-12-06 | 2023-06-02 | 西藏自治区农牧科学院农业研究所 | New use of highland barley cyanidin oxymethyl transferase gene |
WO2023225459A2 (en) | 2022-05-14 | 2023-11-23 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
US20240158457A1 (en) * | 2022-05-20 | 2024-05-16 | Medikine, Inc. | Interleukin-18 receptor binding polypeptides and uses thereof |
CN115976053B (en) * | 2022-12-02 | 2024-04-30 | 四川农业大学 | Duck grass gene related to drought stress and application thereof |
CN116478258B (en) * | 2023-04-21 | 2024-04-05 | 西南大学 | Mulberry cup fungus effector protein Cs02526 and application thereof |
CN118048368B (en) * | 2024-04-11 | 2024-07-12 | 南京农业大学 | Cloning and application of common wheat tillering angle regulating gene tata1-6d |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040031072A1 (en) * | 1999-05-06 | 2004-02-12 | La Rosa Thomas J. | Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement |
US20060123505A1 (en) * | 2002-05-30 | 2006-06-08 | National Institute Of Agrobiological Sciences | Full-length plant cDNA and uses thereof |
US20070067865A1 (en) * | 2000-09-05 | 2007-03-22 | Kovalic David K | Annotated plant genes |
US20070283460A9 (en) * | 1999-05-06 | 2007-12-06 | Jingdong Liu | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
US20090087878A9 (en) * | 1999-05-06 | 2009-04-02 | La Rosa Thomas J | Nucleic acid molecules associated with plants |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6635806B1 (en) * | 1998-05-14 | 2003-10-21 | Dekalb Genetics Corporation | Methods and compositions for expression of transgenes in plants |
US20110131679A2 (en) * | 2000-04-19 | 2011-06-02 | Thomas La Rosa | Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
-
2003
- 2003-11-06 US US10/703,032 patent/US7214786B2/en not_active Expired - Lifetime
-
2007
- 2007-04-16 US US11/785,162 patent/US20110209246A1/en not_active Abandoned
-
2012
- 2012-07-31 US US13/507,812 patent/US20130185831A1/en not_active Abandoned
-
2014
- 2014-02-18 US US14/182,694 patent/US20140259218A1/en not_active Abandoned
-
2016
- 2016-02-18 US US15/047,375 patent/US20160319294A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040031072A1 (en) * | 1999-05-06 | 2004-02-12 | La Rosa Thomas J. | Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement |
US20070283460A9 (en) * | 1999-05-06 | 2007-12-06 | Jingdong Liu | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
US20090087878A9 (en) * | 1999-05-06 | 2009-04-02 | La Rosa Thomas J | Nucleic acid molecules associated with plants |
US20070067865A1 (en) * | 2000-09-05 | 2007-03-22 | Kovalic David K | Annotated plant genes |
US20060123505A1 (en) * | 2002-05-30 | 2006-06-08 | National Institute Of Agrobiological Sciences | Full-length plant cDNA and uses thereof |
Non-Patent Citations (1)
Title |
---|
Sullivan et al, J. Biol. Chem. 266 (35), 22878 (1991) * |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10364437B2 (en) | 2006-12-08 | 2019-07-30 | Iowa State University Research Foundation, Inc. | Plant genes involved in nitrate uptake and metabolism |
US9523099B2 (en) | 2006-12-08 | 2016-12-20 | Iowa State University Research Foundation, Inc. | Plant genes involved in nitrate uptake and metabolism |
US20080141390A1 (en) * | 2006-12-08 | 2008-06-12 | Iowa State University Research Foundation, Inc. | Plant genes involved in nitrate uptake and metabolism |
US9029321B2 (en) | 2011-03-30 | 2015-05-12 | Board Of Regents Of The University Of Texas | Methods and compositions for targeting adipose cells in mammals |
US9539341B2 (en) | 2011-03-30 | 2017-01-10 | Board Of Regents Of The University Of Texas System | Methods and compositions for targeting adipose cells in mammals |
US10842864B2 (en) | 2012-07-27 | 2020-11-24 | City Of Hope | MVA vaccine for delivery of a UL128 complex and preventing CMV infection |
US10376575B2 (en) | 2012-07-27 | 2019-08-13 | City Of Hope | MVA vaccine for delivery of a UL128 complex and preventing CMV infection |
US11717568B2 (en) | 2012-07-27 | 2023-08-08 | City Of Hope | MVA vaccine for delivery of a UL128 complex and preventing CMV infection |
US11512323B2 (en) | 2012-08-27 | 2022-11-29 | Evogene Ltd. | Isolated polynucleotides, polypeptides and methods of using same for increasing abiotic stress tolerance, biomass and yield of plants |
AU2013310979B2 (en) * | 2012-08-27 | 2018-12-13 | Evogene Ltd. | Isolated polynucleotides, polypeptides and methods of using same for increasing abiotic stress tolerance, biomass and yield of plants |
US10858665B2 (en) | 2012-08-27 | 2020-12-08 | Evogene Ltd. | Isolated polynucleotides, polypeptides and methods of using same for increasing abiotic stress tolerance, biomass and yield of plants |
US11485982B1 (en) | 2012-08-27 | 2022-11-01 | Evogene Ltd. | Isolated polynucleotides, polypeptides and methods of using same for increasing abiotic stress tolerance, biomass and yield of plants |
US10487139B2 (en) | 2015-09-10 | 2019-11-26 | City Of Hope | MVA-gh/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereof |
US11384137B2 (en) | 2015-09-10 | 2022-07-12 | City Of Hope | MVA-gH/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereof |
WO2017044895A3 (en) * | 2015-09-10 | 2017-06-08 | City Of Hope | MVA-gH/gL-PC VACCINE DERIVED ANTIBODIES NEUTRALIZING HUMAN CYTOMEGALOVIRUS INFECTIVITY AND METHODS THEREOF |
US11840555B2 (en) | 2015-09-28 | 2023-12-12 | The University Of North Carolina At Chapel Hill | Methods and compositions for antibody-evading virus vectors |
US10745447B2 (en) | 2015-09-28 | 2020-08-18 | The University Of North Carolina At Chapel Hill | Methods and compositions for antibody-evading virus vectors |
US11208438B2 (en) | 2015-09-28 | 2021-12-28 | The University Of North Carolina At Chapel Hill | Methods and compositions for antibody-evading virus vectors |
WO2018129090A1 (en) * | 2017-01-03 | 2018-07-12 | Trellis Bioscience, Llc | Native human antibodies for immune checkpoint modulation targets tim-3 and b7-h3 |
US11046764B2 (en) | 2017-01-03 | 2021-06-29 | Trellis Bioscience, Llc | Native human antibodies for immune checkpoint modulation targets TIM-3 and B7-H3 |
CN107853054A (en) * | 2017-11-22 | 2018-03-30 | 中国热带农业科学院椰子研究所 | Coconut Evaluation of Cold Tolerance method based on mathematical model |
CN108492202A (en) * | 2018-02-12 | 2018-09-04 | 中国农业科学院郑州果树研究所 | A kind of identification method of resistance to overhead flooding injury Germplasm Resources in Genera Actinidia |
US11976096B2 (en) | 2018-04-03 | 2024-05-07 | Ginkgo Bioworks, Inc. | Antibody-evading virus vectors |
US12060390B2 (en) | 2018-04-03 | 2024-08-13 | Ginkgo Bioworks, Inc. | Antibody-evading virus vectors |
US11981914B2 (en) | 2019-03-21 | 2024-05-14 | Ginkgo Bioworks, Inc. | Recombinant adeno-associated virus vectors |
US11905523B2 (en) | 2019-10-17 | 2024-02-20 | Ginkgo Bioworks, Inc. | Adeno-associated viral vectors for treatment of Niemann-Pick Disease type-C |
CN110922457A (en) * | 2019-11-14 | 2020-03-27 | 南京农业大学 | Plant immune induced resistance protein FgPII1 secreted by fusarium graminearum and application thereof |
Also Published As
Publication number | Publication date |
---|---|
US20130185831A1 (en) | 2013-07-18 |
US20140259218A1 (en) | 2014-09-11 |
US20160319294A1 (en) | 2016-11-03 |
US20070044171A1 (en) | 2007-02-22 |
US7214786B2 (en) | 2007-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7214786B2 (en) | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement | |
US7834146B2 (en) | Recombinant polypeptides associated with plants | |
US8106174B2 (en) | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement | |
US8299321B2 (en) | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement | |
US20070283460A9 (en) | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement | |
US20090087878A9 (en) | Nucleic acid molecules associated with plants | |
US20090019601A1 (en) | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement | |
US20040031072A1 (en) | Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement | |
US20070061916A1 (en) | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement | |
US20070011783A1 (en) | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement | |
US20100269213A2 (en) | Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement | |
US20110214206A1 (en) | Nucleic acid molecules and other molecules associated with plants | |
US20060236419A1 (en) | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement | |
US20130097737A1 (en) | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement | |
US20150191739A1 (en) | Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement | |
US20160264984A1 (en) | Soy Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement | |
US20110093981A9 (en) | Nucleic acid molecules and other molecules associated with transcription in plants and uses thereof for plant improvement | |
US20080229439A1 (en) | Nucleic acid molecules and other molecules associated with transcription in plants and uses thereof for plant improvement | |
US20150143581A1 (en) | Nucleic acid molecules and other molecules associated with plants and uses thereof | |
US20110277178A1 (en) | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |